127 results on '"Pierre Dos-Santos"'
Search Results
2. Characterization of the Septal Discontinuity in Ex-Vivo Human Hearts Using Diffusion Tensor Imaging: The Potential Structural Determinism Played by Fiber Orientation in Clinical Phenotype of Laminopathy Patients.
- Author
-
Pierre Cabanis, Julie Magat, Girish Ramlugun, Nestor Pallares-Lupon, Fanny Vaillant, Emma Abell, Laura Bear, Cindy Michel, Philippe Pasdois, Pierre Dos Santos, Marion Constantin, David Benoist, Line Pourtau, Virginie Dubes, Julien Rogier, Louis Labrousse, Mathieu Pernot, Oliver Busuttil, Michel Haïssaguerre, Olivier Bernus, Bruno Quesson, Edward J. Vigmond, Richard D. Walton, Josselin Duchateau, and Valéry Ozenne
- Published
- 2023
- Full Text
- View/download PDF
3. Symmetric Multimodal Mapping of Ex Vivo Cardiac Microstructure of Large Mammalian Whole Hearts for Volumetric Comparison of Myofiber Orientation Estimated from Diffusion MRI and MicroCT.
- Author
-
Valéry Ozenne, Girish Ramlugun, Julie Magat, Nestor Pallares-Lupon, Pierre Cabanis, Pierre Dos Santos, David Benoist, Virginie Dubes, Josselin Duchateau, Louis Labrousse, Michel Haïssaguerre, Olivier Bernus, and Richard D. Walton
- Published
- 2023
- Full Text
- View/download PDF
4. Editorial: Heart failure with preserved ejection fraction: Basic, translational, and clinical research
- Author
-
Fabien Brette, Pierre Dos Santos, and Jean-Sebastien Hulot
- Subjects
heart failure ,disease model ,diastolic dysfunction ,basic mechanisms ,diagnosis ,therapeutic target ,Physiology ,QP1-981 - Published
- 2022
- Full Text
- View/download PDF
5. A IMPORTÂNCIA DA EDUCAÇÃO FÍSICA ESCOLAR NA QUALIDADE DE VIDA DE ESTUDANTES NO ENSINO MÉDIO
- Author
-
Santos, Guilherme Daniel Freitas dos, primary and Melo, Robson Pierre dos Santos, additional
- Published
- 2022
- Full Text
- View/download PDF
6. A Prospective Study to Detect Immune Checkpoint Inhibitors Associated With Myocarditis Among Patients Treated for Lung Cancer
- Author
-
Clara Faubry, Maxime Faure, Anne-Claire Toublanc, Rémi Veillon, Anne-Iris Lemaître, Charlotte Vergnenègre, Hubert Cochet, Sadia Khan, Chantal Raherison, Pierre Dos Santos, and Maeva Zysman
- Subjects
myocarditis ,screening ,immune checkpoint inhibitors ,lung cancer ,early diagnosis ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
BackgroundImmune checkpoint inhibitors (ICIs) are widely used in lung cancer management. However, myocarditis, which is a rare, yet potentially severe adverse-related event associated with ICIs, could be under-reported.ObjectivesThis study is aimed to prospectively evaluate the cumulative incidence rate of myocarditis, through systematic screening, among patients receiving ICIs for lung cancer.MethodsAll patients who received the first administration of ICIs for non-small cell (NSCLC) and small cell lung cancer (SCLC), between May and November 2020, in the pulmonary department of Bordeaux University Hospital, were included. Echocardiography (ECG), troponin-I, and natriuretic peptide dosages before ICIs' first administration and before each infusion were recorded. ECG and magnetic resonance imaging (MRI) were done additionally, in case of at least three times increase in troponin levels, ECG modifications, and the onset of cardiovascular symptoms. Second, if possible, coronarography than endomyocardial biopsy was assessed. The primary outcome was defined as ICIs related to myocarditis onset, while secondary outcomes included other cardiovascular events, disease-free, and overall survival.ResultsDuring the period of interest, 99 patients received their first infusion of ICIs for lung cancer (mean age 64 ± 9 years; 52 men, 67% with adenocarcinoma). Three cases of myocarditis without major adverse cardiac events (MACEs) occurred (two definite and one possible), and the mean duration between the first ICIs' administration and myocarditis onset was 144 ± 3 days. Median disease-free survival and overall survival were 169 [102; 233] days and 209 [147; 249] days, respectively.ConclusionIn our study, systematic screening of myocarditis associated with ICIs leads to a more frequent incidence and a later onset than previously reported. None of them were severe. Additional prospective evidence is needed before we could adopt routine cardiac screening in unselected patients starting ICIs; however, these data shed new light on the risk of myocarditis associated with ICIs administration.
- Published
- 2022
- Full Text
- View/download PDF
7. Clinical profile and midterm prognosis of left ventricular thrombus in heart failure
- Author
-
Anne‐Iris Lemaître, François Picard, Vincent Maurin, Maxime Faure, Pierre Dos Santos, and Nicolas Girerd
- Subjects
Left ventricular thrombus ,Heart failure, systolic ,Dilated cardiomyopathy ,Thromboembolism ,Stroke ,Echocardiography ,Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Abstract Aims We documented the midterm prognosis of left ventricular thrombus (LVT) in heart failure (HF) patients with dilated cardiomyopathy (DCM) and ischaemic cardiomyopathy (ICM). We aimed to characterize patients with LVT in the context of HF with reduced (≤40%) left ventricular ejection fraction and evaluate their risk for death and/or embolic events, overall, and specifically in patients with ischaemic or non‐ischaemic aetiology. We also intended to identify risk factors for LVT in patients with DCM. Methods and results We included all HF patients (N = 105, age 56 ± 13) admitted from 2005 to 2018 in our institution for LVT without significant valve disease/prosthesis, heart transplant/left ventricular assist device, congenital heart disease, or acute myocardial infarction. Our primary endpoint was the 1 year risk of the composite of all‐cause mortality (ACM) and symptomatic embolic events. Mean left ventricular ejection fraction was 23 ± 9%, and median BNP was 1795 pg/mL. Most (97%) patients were treated with vitamin K anticoagulants, and 64% had ICM. Symptomatic embolic events and/or ACM occurred in 20% of the population [embolic events (all within 30 days of LVT diagnosis) 15% and ACM 6%] and was similarly frequent in DCM or ICM (P > 0.05). Suspected/transient embolic events were more frequent in DCM (overall 13%; 29% in DCM vs. 5% in ICM, P
- Published
- 2021
- Full Text
- View/download PDF
8. An old medicine as a new drug to prevent mitochondrial complex I from producing oxygen radicals.
- Author
-
Dominique Detaille, Philippe Pasdois, Audrey Sémont, Pierre Dos Santos, and Philippe Diolez
- Subjects
Medicine ,Science - Abstract
FindingsHere, we demonstrate that OP2113 (5-(4-Methoxyphenyl)-3H-1,2-dithiole-3-thione, CAS 532-11-6), synthesized and used as a drug since 1696, does not act as an unspecific antioxidant molecule (i.e., as a radical scavenger) but unexpectedly decreases mitochondrial reactive oxygen species (ROS/H2O2) production by acting as a specific inhibitor of ROS production at the IQ site of complex I of the mitochondrial respiratory chain. Studies performed on isolated rat heart mitochondria also showed that OP2113 does not affect oxidative phosphorylation driven by complex I or complex II substrates. We assessed the effect of OP2113 on an infarct model of ex vivo rat heart in which mitochondrial ROS production is highly involved and showed that OP2113 protects heart tissue as well as the recovery of heart contractile activity.Conclusion / significanceThis work represents the first demonstration of a drug authorized for use in humans that can prevent mitochondria from producing ROS/H2O2. OP2113 therefore appears to be a member of the new class of mitochondrial ROS blockers (S1QELs) and could protect mitochondrial function in numerous diseases in which ROS-induced mitochondrial dysfunction occurs. These applications include but are not limited to aging, Parkinson's and Alzheimer's diseases, cardiac atrial fibrillation, and ischemia-reperfusion injury.
- Published
- 2019
- Full Text
- View/download PDF
9. Clinical profile and midterm prognosis of left ventricular thrombus in heart failure
- Author
-
François Picard, Anne-Iris Lemaître, Nicolas Girerd, Pierre Dos Santos, Vincent Maurin, Maxime Faure, BOZEC, Erwan, CHU Bordeaux [Bordeaux], Centre de recherche Cardio-Thoracique de Bordeaux [Bordeaux] (CRCTB), Université Bordeaux Segalen - Bordeaux 2-CHU Bordeaux [Bordeaux]-Institut National de la Santé et de la Recherche Médicale (INSERM), IHU-LIRYC, Université Bordeaux Segalen - Bordeaux 2-CHU Bordeaux [Bordeaux], Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Centre d'investigation clinique plurithématique Pierre Drouin [Nancy] (CIC-P), Centre d'investigation clinique [Nancy] (CIC), Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL)-Centre Hospitalier Régional Universitaire de Nancy (CHRU Nancy)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lorraine (UL), Cardiovascular and Renal Clinical Trialists [Vandoeuvre-les-Nancy] (INI-CRCT), Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu [Nancy], and French-Clinical Research Infrastructure Network - F-CRIN [Paris] (Cardiovascular & Renal Clinical Trialists - CRCT )
- Subjects
Adult ,Heart Defects, Congenital ,medicine.medical_specialty ,lcsh:Diseases of the circulatory (Cardiovascular) system ,Heart disease ,medicine.medical_treatment ,Population ,Dilated cardiomyopathy ,Heart failure ,030204 cardiovascular system & hematology ,Ventricular Function, Left ,03 medical and health sciences ,0302 clinical medicine ,[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,Internal medicine ,Original Research Articles ,Thromboembolism ,medicine ,Humans ,030212 general & internal medicine ,Myocardial infarction ,Original Research Article ,cardiovascular diseases ,education ,Left ventricular thrombus ,Heart failure, systolic ,Aged ,education.field_of_study ,Ejection fraction ,business.industry ,Stroke Volume ,Thrombosis ,Middle Aged ,medicine.disease ,Prognosis ,3. Good health ,[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,Stroke ,Echocardiography ,lcsh:RC666-701 ,Ventricular assist device ,Cardiology ,cardiovascular system ,systolic ,Cardiology and Cardiovascular Medicine ,business - Abstract
International audience; Aims: We documented the midterm prognosis of left ventricular thrombus (LVT) in heart failure (HF) patients with dilated cardiomyopathy (DCM) and ischaemic cardiomyopathy (ICM). We aimed to characterize patients with LVT in the context of HF with reduced (≤40%) left ventricular ejection fraction and evaluate their risk for death and/or embolic events, overall, and specifically in patients with ischaemic or non-ischaemic aetiology. We also intended to identify risk factors for LVT in patients with DCM.Methods and results: We included all HF patients (N = 105, age 56 ± 13) admitted from 2005 to 2018 in our institution for LVT without significant valve disease/prosthesis, heart transplant/left ventricular assist device, congenital heart disease, or acute myocardial infarction. Our primary endpoint was the 1 year risk of the composite of all-cause mortality (ACM) and symptomatic embolic events. Mean left ventricular ejection fraction was 23 ± 9%, and median BNP was 1795 pg/mL. Most (97%) patients were treated with vitamin K anticoagulants, and 64% had ICM. Symptomatic embolic events and/or ACM occurred in 20% of the population [embolic events (all within 30 days of LVT diagnosis) 15% and ACM 6%] and was similarly frequent in DCM or ICM (P > 0.05). Suspected/transient embolic events were more frequent in DCM (overall 13%; 29% in DCM vs. 5% in ICM, P < 0.01). Major bleeding occurred in 5% of patients. Left ventricular reverse remodelling occurred in 65% of patients, more frequently in DCM (86% in DCM vs. 65% in ICM, P = 0.02). In a case-control analysis matching DCM patients, BNP level was the only factor significantly associated with LVT (2447 pg/mL in LVT vs. 347 pg/mL, P < 0.001).Conclusions: Patients with LVT have markedly high natriuretic peptides and experience a 20% 1 year risk for embolic events and/or death following diagnosis despite anticoagulant treatment. Most patients have favourable remodelling/recovery. As all symptomatic embolic events occurred within 30 days of LVT diagnosis, a very careful initial management is warranted.
- Published
- 2021
10. How Sodiation Influences the Sucralose Behavior under Electrospray Ionization Mass Spectrometry
- Author
-
Paulo Sales, Katia de Souza, Alyne Bezerra, Satu Ojala, Sérgio de Oliveira, Pierre dos Santos, and Maria Teresa Bara
- Subjects
Analytical Chemistry - Abstract
Nowadays, the detection of sucralose sodium adduct under electrospray ionization in mass spectrometry analysis is a common analysis method, but its high chemical stability is not fully understood. In this work, we use quantum chemistry calculations and mass spectrometry data to understand why sodiated sucralose presents this behavior in mass spectrometry conditions. The potential energy and the position of sodium ions were evaluated using different basis sets in order to comprehend the importance of sodiation in sucralose properties. Quantum-chemical calculations show higher reliability to explain the behavior of sucralose sodium adduct under mass spectrometry conditions, especially when its molecular geometry and potential energies are evaluated.
- Published
- 2022
11. Energy Deregulation Precedes Alteration in Heart Energy Balance in Young Spontaneously Hypertensive Rats: A Non Invasive In Vivo31P-MR Spectroscopy Follow-Up Study.
- Author
-
Veronique Deschodt-Arsac, Laurent Arsac, Julie Magat, Jerome Naulin, Bruno Quesson, and Pierre Dos Santos
- Subjects
Medicine ,Science - Abstract
INTRODUCTION:Gradual alterations in cardiac energy balance, as assessed by the myocardial PCr/ATP-ratio, are frequently associated with the development of cardiac disease. Despite great interest for the follow-up of myocardial PCr and ATP content, cardiac MR-spectroscopy in rat models in vivo is challenged by sensitivity issues and cross-contamination from other organs. METHODS:Here we combined MR-Imaging and MR-Spectroscopy (Bruker BioSpec 9.4T) to follow-up for the first time in vivo the cardiac energy balance in the SHR, a genetic rat model of cardiac hypertrophy known to develop early disturbances in cytosolic calcium dynamics. RESULTS:We obtained consistent 31P-spectra with high signal/noise ratio from the left ventricle in vivo by using a double-tuned (31P/1H) surface coil. Reasonable acquisition time (
- Published
- 2016
- Full Text
- View/download PDF
12. Tissue Preparation Techniques for Contrast-Enhanced Micro Computed Tomography Imaging of Large Mammalian Cardiac Models with Chronic Disease
- Author
-
Richard D. Walton, Philippe Pasdois, Pierre Jaïs, Olivier Bernus, Pierre Dos Santos, Marion Constantin, Jérôme Naulin, Dounia El Hamrani, Stephane Bloquet, Virginie Loyer, Kanchan Kulkarni, Girish S. Ramlugun, Guido Caluori, Bastien Guillot, Jason D. Bayer, and Néstor Pallares-Lupon
- Subjects
Mammals ,Sheep ,General Immunology and Microbiology ,Swine ,General Chemical Engineering ,General Neuroscience ,Myocardium ,Atrial Fibrillation ,Chronic Disease ,Animals ,Heart Atria ,X-Ray Microtomography ,General Biochemistry, Genetics and Molecular Biology - Abstract
Structural remodeling is a common consequence of chronic pathological stresses imposed on the heart. Understanding the architectural and compositional properties of diseased tissue is critical to determine their interactions with arrhythmic behavior. Microscale tissue remodeling, below the clinical resolution, is emerging as an important source of lethal arrhythmia, with high prevalence in young adults. Challenges remain in obtaining high imaging contrast at sufficient microscale resolution for preclinical models, such as large mammalian whole hearts. Moreover, tissue composition-selective contrast enhancement for three-dimensional high-resolution imaging is still lacking. Non-destructive imaging using micro-computed tomography shows promise for high-resolution imaging. The objective was to alleviate sufferance from X-ray over attenuation in large biological samples. Hearts were extracted from healthy pigs (N = 2), and sheep (N = 2) with either induced chronic myocardial infarction and fibrotic scar formation or induced chronic atrial fibrillation. Excised hearts were perfused with: a saline solution supplemented with a calcium ion quenching agent and a vasodilator, ethanol in serial dehydration, and hexamethyldisilizane under vacuum. The latter reinforced the heart structure during air-drying for 1 week. Collagen-dominant tissue was selectively bound by an X-ray contrast-enhancing agent, phosphomolybdic acid. Tissue conformation was stable in air, permitting long-duration microcomputed tomography acquisitions to obtain high-resolution (isotropic 20.7 µm) images. Optimal contrast agent loading by diffusion showed selective contrast enhancement of the epithelial layer and sub-endocardial Purkinje fibers in healthy pig ventricles. Atrial fibrillation (AF) hearts showed enhanced contrast accumulation in the posterior walls and appendages of the atria, attributed to greater collagen content. Myocardial infarction hearts showed increased contrast selectively in regions of cardiac fibrosis, which enabled the identification of interweaving surviving myocardial muscle fibers. Contrast-enhanced air-dried tissue preparations enabled microscale imaging of the intact large mammalian heart and selective contrast enhancement of underlying disease constituents.
- Published
- 2022
13. A IMPORTÂNCIA DA EDUCAÇÃO FÍSICA ESCOLAR NA QUALIDADE DE VIDA DE ESTUDANTES NO ENSINO MÉDIO
- Author
-
Guilherme Daniel Freitas dos Santos and Robson Pierre dos Santos Melo
- Published
- 2022
14. A prospective study to detect ICIs’ associated Myocarditis, among patients treated for lung cancer
- Author
-
Zysman Maeva, Charlotte Vergnenegre, Clara Faubry, Pierre Dos Santos, Chantal Raherison, Hubert Cochet, Maxime Faure, and Remi Veillon
- Subjects
medicine.medical_specialty ,Myocarditis ,business.industry ,Internal medicine ,medicine ,business ,Prospective cohort study ,Lung cancer ,medicine.disease - Published
- 2021
15. Integrative Methods for Studying Cardiac Energetics
- Author
-
Philippe Diolez, Véronique Deschodt-Arsac, Guillaume Calmettes, Gilles Gouspillou, Laurent Arsac, Pierre Jais, Michel Haissaguerre, and Pierre dos Santos
- Published
- 2021
16. B-PO02-032 SUCCINATE ACCUMULATION IN ATRIAL CARDIOMYOCYTES INCREASES MITOCHONDRIAL REVERSE ELECTRON FLUX, OXIDATIVE STRESS, AND MIGHT PARTICIPATE TO AF STABILIZATION IN THE SHEEP
- Author
-
Philippe Diolez, Guido Caluori, Valentin Meillet, Sylvain Ploux, Bastien Guillot, Stéphane N. Hatem, Pierre Dos Santos, Emma Abell, Philipp Krisai, Rémi Dubois, Andreas Häberlin, Farid Ichou, Olivier Bernus, Hassan-Adam Mahamat, Pierre Jaïs, Tsukasa Kamakura, Virginie Loyer, Philippe Pasdois, Fanny Vaillant, and Mélèze Hocini
- Subjects
business.industry ,Electron flux ,Physiology (medical) ,Biophysics ,Medicine ,Cardiology and Cardiovascular Medicine ,business ,medicine.disease_cause ,Oxidative stress - Published
- 2021
17. Cardiac Resynchronization Therapy Reduces Metaboreflex Contribution to the Ventilatory Response in Heart Failure Population
- Author
-
Jérémie Jaussaud, Laurie Aimable, Pierre Bordachar, Pierre Dos Santos, Laurent Barandon, Philippe Ritter, Raymond Roudaut, and Hervé Douard
- Subjects
Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
Background. Metaboreflex overactivation has been proprosed to explain exaggerated hyperventilation in heart failure population. We investigated the metaboreflex activation after cardiac resynchronization therapy (CRT). Methods. 10 heart failure patients (mean left ventricular ejection fraction (LVEF) 27±4%) schedulded for CRT implantation were prospectively studied. At baseline and after 6 month follow up two maximal cardiopulmonary exercise tests with and without regional circulatory occlusion (RCO) during recovery were performed. RCO was achieved by inflation of bilateral upper thigh tourniquets 30 mmHg above peak systolic blood pressure during 3 minutes after peak exercise. Metaboreflex contribution to the ventilatory response was assessed as the difference in ventilatory data at the third minute during recovery between the two tests (Δ). Results. Patients had enhanced VE/VCO2 slope (40±9) and an evident metaboreflex contribution to the high ventilatory response (ΔVE: 3±4 L/min; 𝑃=0.05, ΔRR: 4.5±4/min; 𝑃=0.003 and ΔVE/VCO2: 5.5±4; 𝑃=0.007). 6 months after CRT implantation, NYHA class, LVEF, peak VO2 and VE/VCO2 were significantly improved (1.4±0.5; 𝑃
- Published
- 2012
- Full Text
- View/download PDF
18. Electrical storm in the early phase of HeartMate® II device implantation: Incidence, risk factors and prognosis
- Author
-
Rodrigue Garcia, Michel Haïssaguerre, Jérôme Corré, François Picard, Arnaud Denis, Nicolas Derval, Antoine Romen, Karine Nubret, Pierre Dos Santos, Pierre Jaïs, Adlane Zemmoura, Laurent Barandon, and Frederic Sacher
- Subjects
Body surface area ,medicine.medical_specialty ,Ejection fraction ,business.industry ,medicine.medical_treatment ,Mortality rate ,Cardiomyopathy ,General Medicine ,030204 cardiovascular system & hematology ,medicine.disease ,Extracorporeal ,Discontinuation ,Transplantation ,03 medical and health sciences ,0302 clinical medicine ,Ventricular assist device ,Internal medicine ,medicine ,Cardiology ,030212 general & internal medicine ,Cardiology and Cardiovascular Medicine ,business - Abstract
Summary Background Ventricular arrhythmia is common after left ventricular assist device (LVAD) implantation, especially in the early postoperative phase ( Aim To identify the incidence of and risk factors for electrical storm (ES) occurring within 30 days of HeartMate ® II implantation. Methods We reviewed data from all consecutive patients undergoing HeartMate ® II device implantation at our institution from January 2008 to December 2014. Patient demographic data, pharmacotherapies and outcomes were collected. The primary endpoint was occurrence of early ES (within 30 days of surgery), defined as three or more separate episodes of sustained ventricular arrhythmia within a 24-hour interval, requiring appropriate therapy. Results Forty-three patients (mean age 56.7 ± 11.2 years; 39 men) were included. At HeartMate ® II implantation, mean left ventricular ejection fraction was 20 ± 5%, 32 (74.4%) patients had ischaemic cardiomyopathy and 31 (72.1%) were implanted with an indication of bridge to cardiac transplantation. During follow-up, 12 (27.9%) patients experienced early ES after HeartMate ® II implantation (median delay 9.1 ± 7.8 days). Early ES was more frequent in larger patients (body surface area 1.99 vs 1.81 m 2 ; P P = 0.08), previous implantable cardioverter-defibrillator implantation (66.7% vs 38.7%; P = 0.09), discontinuation of long-term beta-blocker therapy (75.0% vs 45.2%; P = 0.08), weaning of adrenergic drugs after the third day (66.7% vs 35.5%; P = 0.06) and the use of extracorporeal life support (50% vs 22.6%; P = 0.079), but was not associated with the cardiomyopathy aetiology or the indication for assistance. Catheter ventricular tachycardia ablation was performed in six (14.0%) patients. Early ES was associated with a significantly higher all-cause mortality rate at the 30th day (33.3% vs 6.5%; P = 0.02). Conclusion ES is a common and pejorative feature in the early postoperative period.
- Published
- 2018
19. Adjustment and Characterization of an Original Model of Chronic Ischemic Heart Failure in Pig
- Author
-
Laurent Barandon, Joachim Calderon, Patricia Réant, Dominique Caillaud, Stéphane Lafitte, Xavier Roques, Thierry Couffinhal, and Pierre Dos Santos
- Subjects
Diseases of the circulatory (Cardiovascular) system ,RC666-701 - Abstract
We present and characterize an original experimental model to create a chronic ischemic heart failure in pig. Two ameroid constrictors were placed around the LAD and the circumflex artery. Two months after surgery, pigs presented a poor LV function associated with a severe mitral valve insufficiency. Echocardiography analysis showed substantial anomalies in radial and circumferential deformations, both on the anterior and lateral surface of the heart. These anomalies in function were coupled with anomalies of perfusion observed in echocardiography after injection of contrast medium. No demonstration of myocardial infarction was observed with histological analysis. Our findings suggest that we were able to create and to stabilize a chronic ischemic heart failure model in the pig. This model represents a useful tool for the development of new medical or surgical treatment in this field.
- Published
- 2010
- Full Text
- View/download PDF
20. Current aspects of the spectrum of acute heart failure syndromes in a real-life setting: the OFICA study
- Author
-
Logeart, Damien, Isnard, Richard, Resche-Rigon, Matthieu, Seronde, Marie-France, de Groote, Pascal, Jondeau, Guillaume, Galinier, Michel, Mulak, Geneviève, Donal, Erwan, Delahaye, François, Juilliere, Yves, Damy, Thibaud, Jourdain, Patrick, Bauer, Fabrice, Eicher, Jean-Christophe, Neuder, Yannick, Trochu, Jean-Noël, Chantal, Ache Papillon, Nadia, Aissaoudi, François, Aupetit Jean, Christian, Baietto, Noël, Baille, Serge, Baleynaud, Jacques, Ballout, Claude, Barnay, Fabrice, Bauer, Bechetoille, Mohammed, Belhameche, Loïc, Belle, Sandrine, Bentzinger, Alain, Bergere, Philippe, Bernadet, Marie, Perron Jean, François, Bernasconi, Samia, Berranen, Annick, Bineau-Jorisse, Michel, Serrano, Christian, Boureux, Salim, Boutalba, Erik, Bouvier, Marc, Bouvier Jean, Françoise, Bragard Marie, Philippe, Brunel, Roland, Carlioz, Christophe, Charniot Jean, Christophe, Chavelas, Saïda, Cheggour, Pascal, Chevalet, Vlad, Ciobotaru, René, Codjia, Alain, Cohen Solal, Patrick, Coulon, Daniel, Czitrom, Nicolas, Dahdal, Philippe, De Corbiere, Pascal, De Groote, Olivier, De Sauniere, France, Deforet Marie, Alain, Lassabe, Michel, Mansour, François, Delahaye, Michel, Chuzeville, Arnaud, Dellinger, Jacques, Denis, Gilles, Dentan, Michèle, Desruennes, Sylvain, Destrac, Claude, Dib Jean, Rodies, Dimitriou, Philippe, Doazan Jean, Erwan, Donal, Pierre, Matali, Pierre, Dos Santos, Roland, Sananes, Jacques, Dujardin Jean, Hervé, Gallois, Eric, Durand, Michel, Desnos, Sophie, Durand, Florence, Durup, Laurent, Dutoit, J-C, Eicher, Abdellatif, El Hallak, Mariam, Elkohen, Elodie, Faveau, Michèle, Escande, Jean, Ettori, Laurent, Fauchier, François, Maillot, Jean-Pierre, Favier, Bertrand, Fontan, Patrick, Friocourt, Philippe, Fromage, Michel, Galinier, Daniel, Galley, Erik, Garbarz, Philippe, Garcon, Daniel, Garnier, Cédric, Gaxatte, Frédéric, Georger, Renaud, Gervais, Nachwan, Ghanem, Géraldine, Gibault, Clément, Charbonnel, Pierre, Gibelin, Patrice, Brocker, Michel, Gofard, Mohand, Goudjil, Gilbert, Habib, Maryline, Hamdan-Challe, Olivier, Hanon, Michèle, Pinson, Luc, Hittinger, David, Houpe, Agnes, Hyverts, Eva, Inorowicz, Richard, Isnard, Adi, Issa, Muntaser P, Jamal, Luc, Jannin-Manificat, Guillaume, Jondeau, Patrick, Jourdain, Marc, Joussen Jean, Alain, Juillard, Yves, Juilliere, David, Kenizou, Barbara, Lambert, Skander, Khechine, Robin, Zelinsky, Pierre, Lagorce, Maryse, Lescure, Pierre, Lantelme, Thierry, Laperche, Fabrice, Larrazet, Evelyne, Laurent, Philippe, Le Metayer, Patrick, Assyag, Julien, Lemoine, Rémy, Lepori, Benoit, Lequeux, Guillaume, Lhernault, Christine, Machuron, Dominique, Magnin, Nam, Mai, Hamid, Makki, Mounia, Malou, J Jacques, Marier, Jean-Pierre, Maroni, Michel, Martelet, Colette, Matagrin, Nicolas, Coquerel, Mestre-Fernandes, Damien, Metz, Christophe, Meune, Laurent, Michel, Sandrine, Migran, Olivier, Milleron, Catherine, Mimran, Christian, Montagnier, Christophe, Moreau, Yannick, Neuder, Laurent, Orion, Blandine, Ouattara, Joël, Belmin, Eric, Perchicot, Sandrine, Peyrot, Laurent, Poirette, Philippe, Pon-Gabrielsen, Isabelle, Poulain, Fabrice, Prunier, Mamy, Randriamora, Pierre, Raphael, Charles, Raynaud Jean, Guy, Rebuffat, Michel, Remond, Franck, Revel, François, Roubille, Rémi, Sabatier, Raïf, Sader, Robert, Sal, Carole, Saudubray, France, Seronde Marie, François-Xavier, Soto, Jocelyn, Souk Aloun, Benoit, Spillemaecker, Adel, Srour, Yves, Tabet Jean, Michel, Tartiere Jean, Guy, Thourot, Thierry, Tibi, Christophe, Tribouilloy, Noël, Trochu Jean, Eric, Verbrugge, François, Vinchon, and Khelil, Yaici
- Published
- 2013
- Full Text
- View/download PDF
21. Laminados cerâmicos e preparos minimamente invasivos associados ao clareamento dental
- Author
-
Santi, Marina Rodrigues, primary, Noronha, Mayara dos Santos, additional, Guarato, Fernanda Rodrigues Borges Amaral, additional, and Caldeira, Milena Maria Pierre dos Santos, additional
- Published
- 2020
- Full Text
- View/download PDF
22. B-PO02-025 NON-INVASIVE ELECTRICAL IMAGING OF REPOLARIZATION ABNORMALITIES TO PREDICT ARRHYTHMIC RISK
- Author
-
Julien Roger, Matthijs J. M. Cluitmans, Ruben Coronel, Rémi Dubois, Laura Bear, Louis Labrousse, Olivier Bernus, Pierre Dos Santos, Emma Abell, and Michel Haïssaguerre
- Subjects
medicine.medical_specialty ,Arrhythmic risk ,Electrical imaging ,business.industry ,Physiology (medical) ,Internal medicine ,Non invasive ,Cardiology ,medicine ,Repolarization ,Cardiology and Cardiovascular Medicine ,business - Published
- 2021
23. Five-Year Clinical Outcome and Valve Durability After Transcatheter Aortic Valve Replacement in High-Risk Patients
- Author
-
Romain, Didier, Hélène, Eltchaninoff, Patrick, Donzeau-Gouge, Karine, Chevreul, Jean, Fajadet, Pascal, Leprince, Alain, Leguerrier, Michel, Lièvre, Alain, Prat, Emmanuel, Teiger, Thierry, Lefevre, Didier, Tchetché, Didier, Carrié, Dominique, Himbert, Bernard, Albat, Alain, Cribier, Arnaud, Sudre, Didier, Blanchard, Gilles, Rioufol, Frederic, Collet, Remi, Houel, Pierre, Dos Santos, Nicolas, Meneveau, Said, Ghostine, Thibaut, Manigold, Philippe, Guyon, Thomas, Cuisset, Herve, Le Breton, Stephane, Delepine, Xavier, Favereau, Geraud, Souteyrand, Patrick, Ohlmann, Vincent, Doisy, Thérèse, Lognoné, Antoine, Gommeaux, Jean-Philippe, Claudel, Francois, Bourlon, Bernard, Bertrand, Bernard, Iung, and Martine, Gilard
- Subjects
Aged, 80 and over ,Heart Failure ,Male ,Time Factors ,Hemodynamics ,Aortic Valve Stenosis ,Survival Analysis ,Stroke ,Transcatheter Aortic Valve Replacement ,Treatment Outcome ,Risk Factors ,Humans ,Equipment Failure ,Female ,Registries ,Aged ,Follow-Up Studies ,Proportional Hazards Models - Abstract
The FRANCE-2 registry (French Aortic National Corevalve and Edwards) previously reported good early- and medium-term clinical and echocardiographic efficacy for transcatheter aortic valve replacement. We here report 5-year follow-up results from the registry.The registry includes all consecutive patients undergoing transcatheter aortic valve replacement for severe aortic stenosis in France. Follow-up is scheduled at 30 days, 6 months, then annually from 1 to 5 years. Clinical events were defined according to the Valve Academic Research Consortium criteria, and hemodynamic structural valve deterioration (SVD) was defined according to the consensus statement by the European Association of Percutaneous Cardiovascular Interventions.Between January 2010 and January 2012, 4201 patients were enrolled in 34 centers. Five-year vital status was available for 95.5% of patients; 88.1% had clinical evaluation or died. Overall, at 5 years, all-cause mortality was 60.8% (n=2478; 95% CI, 59.3% to 62.3%). The majority of cardiovascular events occurred in the first month after valve implantation, and incidence remained low thereafter, at2% per year up to 5 years, except for heart failure. The rate of heart failure was 14.3% at 1 year, then decreased over time to5% per year. In cumulative incidence function, the rates of severe SVD and moderate/severe SVD at 5 years were 2.5% and 13.3%, respectively. Mortality did not differ between patients with or without severe SVD (hazard ratio, 0.71; 95% CI, 0.47-1.07; P=0.1). Finally, in the population of patients with severe SVD, 1 patient (1.7%) experienced a stroke, and 8 patients presented ≥1 heart failure event (13.3%).The 5-year follow-up results of the FRANCE-2 registry represent the largest long-term data set available in a high-risk population. In surviving patients, the low rate of clinical events and the low level of SVD after 1 year support the long-term efficacy of transcatheter aortic valve replacement in both types of transcatheter prosthesis featuring in the registry.
- Published
- 2018
24. Late Outcomes of Transcatheter Aortic Valve Replacement in High-Risk Patients
- Author
-
Martine Gilard, Hélène Eltchaninoff, Patrick Donzeau-Gouge, Karine Chevreul, Jean Fajadet, Pascal Leprince, Alain Leguerrier, Michel Lievre, Alain Prat, Emmanuel Teiger, Thierry Lefevre, Didier Tchetche, Didier Carrié, Dominique Himbert, Bernard Albat, Alain Cribier, Arnaud Sudre, Didier Blanchard, Gilles Rioufol, Frederic Collet, Remi Houel, Pierre Dos Santos, Nicolas Meneveau, Said Ghostine, Thibaut Manigold, Philippe Guyon, Dominique Grisoli, Herve Le Breton, Stephane Delpine, Romain Didier, Xavier Favereau, Geraud Souteyrand, Patrick Ohlmann, Vincent Doisy, Gilles Grollier, Antoine Gommeaux, Jean-Philippe Claudel, Francois Bourlon, Bernard Bertrand, Marc Laskar, Bernard Iung, Michel Bertrand, Jean Cassagne, Jacques Boschat, Jean Rene Lusson, Pierre Mathieu, Yves Logeais, Jean-Paul Bessou, Bernard Chevalier, Arnaud Farge, Philippe Garot, Thomas Hovasse, Marie Claude Morice, Mauro Romano, Patrick Donzeau Gouge, Olivier Vahdat, Bruno Farah, Didier Carrie, Nicolas Dumonteil, Gérard Fournial, Bertrand Marcheix, Patrick Nataf, Alec Vahanian, Florence Leclercq, Christophe Piot, Laurent Schmutz, Pierre Aubas, A. du Cailar, A. Dubar, N. Durrleman, F. Fargosz, Gilles Levy, Eric Maupas, François Rivalland, G. Robert, Christophe Tron, Francis Juthier, Thomas Modine, Eric Van Belle, Carlo Banfi, Thierry Sallerin, Olivier Bar, Christophe Barbey, Stephan Chassaing, Didier Chatel, Olivier Le Page, Arnaud Tauran, Daniele Cao, Raphael Dauphin, Guy Durand de Gevigney, Gérard Finet, Olivier Jegaden, Jean-François Obadia, Farzin Beygui, Jean-Philippe Collet, Alain Pavie, Frédéric Collet, null Pecheux, null Bayet, Alain Vaillant, Jacques Vicat, Olivier Wittenberg, Rémi Houel, Patrick Joly, Roger Rosario, Patrice Bergeron, Jacques Bille, Richard Gelisse, Jean-Paul Couetil, Jean-Luc Dubois Rande, Delphine Hayat, Emilie Fougeres, Jean-Luc Monin, Gauthier Mouillet, Florence Arsac, Emmanuel Choukroun, Marina Dijos, Jean-Philippe Guibaud, Lionel Leroux, Nicolas Elia, null Descotes Genon, Sidney Chocron, François Schiele, Christophe Caussin, Alexandre Azmoun, Saïd Ghostine, Rémi Nottin, Ashok Tirouvanziam, Dominique Crochet, Régis Gaudin, Jean-Christian Roussel, Nicolas Bonnet, Franck Digne, Patrick Mesnidrey, Thierry Royer, Victor Stratiev, Jean-Louis Bonnet, Thomas Cuisset, Hervé Le Breton, Issal Abouliatim, Marc Bedossa, Dominique Boulmier, Jean Philippe Verhoye, Stéphane Delepine, Jean-Louis Debrux, Alain Furber, Frédéric Pinaud, Eric Bezon, Jean-Noel Choplain, Oliver Bical, Grégoire Dambrin, Philippe Deleuze, Arnaud Jegou, Jean-René Lusson, Kasra Azarnouch, Nicolas Durel, Andrea Innorta, Géraud Souteyrand, Yves Lienhart, Ricardo Roriz, Patrick Staat, Jean-Noël Fabiani, Antoine Lafont, Rachid Zegdi, Didier Heudes, Michel Kindo, Jean-Philippe Mazzucotelli, Michel Zupan, Calin Ivascau, Thérèse Lognone, Massimo Massetti, Rémy Sabatier, Bruno Huret, Philippe Hochart, Damien Bouchayer, François Gabrielle, Franck Pelissier, Guillaume Tremeau, François Bourlon, Gilles Dreyfus, Armand Eker, Yakoub Habib, Nicolas Hugues, Claude Mialhe, Olivier Chavanon, Paolo Porcu, and Gérald Vanzetto
- Subjects
medicine.medical_specialty ,Framingham Risk Score ,Transcatheter aortic ,business.industry ,Incidence (epidemiology) ,medicine.medical_treatment ,030204 cardiovascular system & hematology ,medicine.disease ,3. Good health ,Surgery ,03 medical and health sciences ,Stenosis ,0302 clinical medicine ,Valve replacement ,Aortic valve stenosis ,medicine ,030212 general & internal medicine ,Cardiology and Cardiovascular Medicine ,Risk assessment ,business ,Prospective cohort study - Abstract
BACKGROUND Transcatheter aortic valve replacement (TAVR) has revolutionized management of high-risk patients with severe aortic stenosis. However, survival and the incidence of severe complications have been assessed in relatively small populations and/or with limited follow-up. OBJECTIVES This report details late clinical outcome and its determinants in the FRANCE-2 (FRench Aortic National CoreValve and Edwards) registry. METHODS The FRANCE-2 registry prospectively included all TAVRs performed in France. Follow-up was scheduled at 30 days, at 6 months, and annually from 1 to 5 years. Standardized VARC (Valve Academic Research Consortium) outcome definitions were used. RESULTS A total of 4,201 patients were enrolled between January 2010 and January 2012 in 34 centers. Approaches were transarterial (transfemoral 73%, transapical 18%, subclavian 6%, and transaortic or transcarotid 3%) or, in 18% of patients, transapical. Median follow-up was 3.8 years. Vital status was available for 97.2% of patients at 3 years. The 3-year all-cause mortality was 42.0% and cardiovascular mortality was 17.5%. In a multivariate model, predictors of 3-year all-cause mortality were male sex (p = 2 of 4 (p < 0.001). Severe events according to VARC criteria occurred mainly during the first month and subsequently in < 2% of patients/year. Mean gradient, valve area, and residual aortic regurgitation were stable during follow-up. CONCLUSIONS The FRANCE-2 registry represents the largest database available on late results of TAVR. Late mortality is largely related to noncardiac causes. Incidence rates of severe events are low after the first month. Valve performance remains stable over time. (J Am Coll Cardiol 2016; 68: 1637-47) (C) 2016 by the American College of Cardiology Foundation.
- Published
- 2016
25. Magnetic resonance-compatible model of isolated working heart from large animal for multimodal assessment of cardiac function, electrophysiology, and metabolism
- Author
-
Pierre Bour, Fanny Vaillant, Pierre Dos Santos, Philippe Ritter, Virginie Loyer, Julie Magat, Delphine Vieillot, Bruno Quesson, Jérôme Naulin, Louis Labrousse, David Benoist, and Olivier Bernus
- Subjects
In vivo magnetic resonance spectroscopy ,Cardiac function curve ,Pathology ,medicine.medical_specialty ,Magnetic Resonance Spectroscopy ,Phosphocreatine ,Physiology ,Sus scrofa ,Action Potentials ,Hemodynamics ,030204 cardiovascular system & hematology ,Ventricular Function, Left ,030218 nuclear medicine & medical imaging ,03 medical and health sciences ,Adenosine Triphosphate ,0302 clinical medicine ,Heart Rate ,Physiology (medical) ,Mitral valve ,Internal medicine ,Ventricular Pressure ,medicine ,Animals ,Arterial Pressure ,Sheep, Domestic ,Ejection fraction ,medicine.diagnostic_test ,business.industry ,Myocardium ,Heart ,Isolated Heart Preparation ,Stroke Volume ,Magnetic resonance imaging ,Magnetic Resonance Imaging ,Perfusion ,Kinetics ,medicine.anatomical_structure ,Ventricle ,Ventricular Function, Right ,cardiovascular system ,Cardiology ,Feasibility Studies ,Electrophysiologic Techniques, Cardiac ,Energy Metabolism ,Cardiology and Cardiovascular Medicine ,business - Abstract
To provide a model close to the human heart, and to study intrinsic cardiac function at the same time as electromechanical coupling, we developed a magnetic resonance (MR)-compatible setup of isolated working perfused pig hearts. Hearts from pigs (40 kg, n = 20) and sheep ( n = 1) were blood perfused ex vivo in the working mode with and without loaded right ventricle (RV), for 80 min. Cardiac function was assessed by measuring left intraventricular pressure and left ventricular (LV) ejection fraction (LVEF), aortic and mitral valve dynamics, and native T1 mapping with MR imaging (1.5 Tesla). Potential myocardial alterations were assessed at the end of ex vivo perfusion from late-Gadolinium enhancement T1 mapping. The ex vivo cardiac function was stable across the 80 min of perfusion. Aortic flow and LV-dP/d tmin were significantly higher ( P < 0.05) in hearts perfused with loaded RV, without differences for heart rate, maximal and minimal LV pressure, LV-dP/d tmax, LVEF, and kinetics of aortic and mitral valves. T1 mapping analysis showed a spatially homogeneous distribution over the LV. Simultaneous recording of hemodynamics, LVEF, and local cardiac electrophysiological signals were then successfully performed at baseline and during electrical pacing protocols without inducing alteration of MR images. Finally, 31P nuclear MR spectroscopy (9.4 T) was also performed in two pig hearts, showing phosphocreatine-to-ATP ratio in accordance with data previously reported in vivo. We demonstrate the feasibility to perfuse isolated pig hearts in the working mode, inside an MR environment, allowing simultaneous assessment of cardiac structure, mechanics, and electrophysiology, illustrating examples of potential applications.
- Published
- 2016
26. Cardiac Contractility Modulation in a Model of Repaired Tetralogy of Fallot: A Sheep Model
- Author
-
Louis Labrousse, François Roubertie, Michel Haïssaguerre, Sylvain Ploux, Pierre Dos Santos, Caroline Rooryck, Romain Eschalier, Jean-Benoit Thambo, Pierre Bordachar, Adlane Zemmoura, and Philippe Ritter
- Subjects
medicine.medical_specialty ,Heart disease ,Heart Ventricles ,Ventricular Dysfunction, Right ,Hemodynamics ,030204 cardiovascular system & hematology ,Cardiac contractility modulation ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,medicine ,Animals ,In patient ,030212 general & internal medicine ,Tetralogy of Fallot ,Sheep ,business.industry ,Vascular surgery ,medicine.disease ,Myocardial Contraction ,Cardiac surgery ,Heart failure ,Pediatrics, Perinatology and Child Health ,Ventricular Function, Right ,cardiovascular system ,Cardiology ,Cardiology and Cardiovascular Medicine ,business - Abstract
The onset of right ventricular dysfunction in patients presenting with congenital heart disease is associated with a dismal long-term outcome and often represents a therapeutic dead end. Our study had several objectives: (1) to analyse the anatomical, functional, histological and cellular characteristics of an animal model of repaired tetralogy of Fallot with right ventricular dysfunction (2) to test the new electrical treatment known as cardiac contractility modulation in this animal model. Seven sheep underwent a first surgery at the age of three weeks aiming to mimic the characteristics of a repaired tetralogy of Fallot. Five controls were sham-operated. Experimental studies were performed 12 months after the initial operation. The hemodynamic, echocardiographic, and mitochondrial function studies were carried out before and after cardiac contractility modulation in closed- and open-chest conditions. In this animal model of right ventricular dysfunction, short-term cardiac contractility modulation was associated with a significant improvement in (a) right ventricular function, as evidenced by a significant increase in right ventricular dP/dt (p
- Published
- 2016
27. Five-Year Clinical Outcome and Valve Durability After Transcatheter Aortic Valve Replacement in High-Risk Patients: FRANCE-2 Registry
- Author
-
Nicolas Meneveau, Said Ghostine, G. Rioufol, Dominique Himbert, Stéphane Delépine, Philippe Guyon, Jean Fajadet, Frederic Collet, Martine Gilard, Didier Carrié, Alain Cribier, Patrick Ohlmann, Arnaud Sudre, Pascal Leprince, Michel Lievre, Thierry Lefèvre, Pierre Dos Santos, Thérèse Lognoné, Bernard Bertrand, Alain Prat, Didier Tchetche, Xavier Favereau, Thibaut Manigold, Jean-Philippe Claudel, Bernard Albat, Alain Leguerrier, Patrick Donzeau-Gouge, Hélène Eltchaninoff, Géraud Souteyrand, Bernard Iung, Antoine Gommeaux, Thomas Cuisset, Francois Bourlon, Remi Houel, Emmanuel Teiger, Didier Blanchard, Karine Chevreul, Hervé Le Breton, Romain Didier, Vincent Doisy, Laboratoire d'Electronique et des Technologies de l'Information (CEA-LETI), Direction de Recherche Technologique (CEA) (DRT (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Université Grenoble Alpes (UGA), Optimisation des régulations physiologiques (ORPHY (EA 4324)), Université de Brest (UBO)-Centre Hospitalier Régional Universitaire de Brest (CHRU Brest)-Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO), Clinique St Hilaire ( Service de Cardiologie, Rouen), Epidémiologie Clinique et Evaluation Economique Appliquées aux Populations Vulnérables (ECEVE (U1123 / UMR_S_1123)), AP-HP Hôpital universitaire Robert-Debré [Paris]-Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de cardiologie [CHU Pitié-Salpêtrière], Assistance publique - Hôpitaux de Paris (AP-HP) (APHP)-CHU Pitié-Salpêtrière [APHP], Laboratoire Traitement du Signal et de l'Image (LTSI), Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES)-Institut National de la Santé et de la Recherche Médicale (INSERM), Evaluation et modélisation des effets thérapeutiques, Département biostatistiques et modélisation pour la santé et l'environnement [LBBE], Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Laboratoire de Biométrie et Biologie Evolutive - UMR 5558 (LBBE), Université de Lyon-Université de Lyon-Institut National de Recherche en Informatique et en Automatique (Inria)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS), Service de cardiologie [Toulouse], Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-CHU Toulouse [Toulouse]-Hôpital de Rangueil, CHU Toulouse [Toulouse], Centre Hospitalier Régional Universitaire [Montpellier] (CHRU Montpellier), Institut de génétique humaine (IGH), Université de Montpellier (UM)-Centre National de la Recherche Scientifique (CNRS), Cardiovasculaire, métabolisme, diabétologie et nutrition (CarMeN), Institut National de la Recherche Agronomique (INRA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Bordeaux Ségalen [Bordeaux 2], Max Planck Institute for Chemistry (MPIC), Max-Planck-Gesellschaft, Nutrition, obésité et risque thrombotique (NORT), Institut National de la Recherche Agronomique (INRA)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre recherche en CardioVasculaire et Nutrition (C2VN), Service de cardiologie et maladies vasculaires [CHU de Rennes], CHU Pontchaillou [Rennes], Service de cardiologie, Hôpitaux Universitaires de Strasbourg, Commissariat à l'énergie atomique et aux énergies alternatives - Laboratoire d'Electronique et de Technologie de l'Information (CEA-LETI), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM)-AP-HP Hôpital universitaire Robert-Debré [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Université de Rennes (UR)-Institut National de la Santé et de la Recherche Médicale (INSERM), Service Cardiologie [CHU Toulouse], Pôle Cardiovasculaire et Métabolique [CHU Toulouse], Centre Hospitalier Universitaire de Toulouse (CHU Toulouse)-Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Centre recherche en CardioVasculaire et Nutrition = Center for CardioVascular and Nutrition research (C2VN), Service de cardiologie et maladies vasculaires [Rennes] = Cardiac, Thoracic, and Vascular Surgery [Rennes], Institut Brestois Santé Agro Matière (IBSAM), Université de Brest (UBO)-Université de Brest (UBO)-Université de Brest (UBO)-Centre Hospitalier Régional Universitaire de Brest (CHRU Brest), Institut National de la Santé et de la Recherche Médicale (INSERM)-AP-HP Hôpital universitaire Robert-Debré [Paris]-Université Paris Diderot - Paris 7 (UPD7), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Hospices Civils de Lyon (HCL), Institut National de la Santé et de la Recherche Médicale (INSERM)-AP-HP Hôpital universitaire Robert-Debré [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Université Paris Diderot - Paris 7 (UPD7), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU), Hôpital de Rangueil, CHU Toulouse [Toulouse]-CHU Toulouse [Toulouse], Hospices Civils de Lyon (HCL)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Institut National de la Recherche Agronomique (INRA), and Aix Marseille Université (AMU)-Institut National de la Recherche Agronomique (INRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
medicine.medical_specialty ,cardiology esc ,Transcatheter aortic ,definitions ,medicine.medical_treatment ,[SDV]Life Sciences [q-bio] ,030204 cardiovascular system & hematology ,outcomes ,03 medical and health sciences ,0302 clinical medicine ,Valve replacement ,Physiology (medical) ,medicine ,Long term outcomes ,implantation ,030212 general & internal medicine ,ComputingMilieux_MISCELLANEOUS ,european association ,High risk patients ,business.industry ,heart-failure ,medicine.disease ,3. Good health ,Surgery ,predictors ,society ,Heart failure ,Cardiovascular System & Cardiology ,transcatheter aortic valve replacement ,pathology ,Cardiology and Cardiovascular Medicine ,business ,heart valves ,long-term outcomes - Abstract
Background: The FRANCE-2 registry (French Aortic National Corevalve and Edwards) previously reported good early- and medium-term clinical and echocardiographic efficacy for transcatheter aortic valve replacement. We here report 5-year follow-up results from the registry. Methods: The registry includes all consecutive patients undergoing transcatheter aortic valve replacement for severe aortic stenosis in France. Follow-up is scheduled at 30 days, 6 months, then annually from 1 to 5 years. Clinical events were defined according to the Valve Academic Research Consortium criteria, and hemodynamic structural valve deterioration (SVD) was defined according to the consensus statement by the European Association of Percutaneous Cardiovascular Interventions. Results: Between January 2010 and January 2012, 4201 patients were enrolled in 34 centers. Five-year vital status was available for 95.5% of patients; 88.1% had clinical evaluation or died. Overall, at 5 years, all-cause mortality was 60.8% (n=2478; 95% CI, 59.3% to 62.3%). The majority of cardiovascular events occurred in the first month after valve implantation, and incidence remained low thereafter, at P =0.1). Finally, in the population of patients with severe SVD, 1 patient (1.7%) experienced a stroke, and 8 patients presented ≥1 heart failure event (13.3%). Conclusions: The 5-year follow-up results of the FRANCE-2 registry represent the largest long-term data set available in a high-risk population. In surviving patients, the low rate of clinical events and the low level of SVD after 1 year support the long-term efficacy of transcatheter aortic valve replacement in both types of transcatheter prosthesis featuring in the registry.
- Published
- 2018
28. Calcium Channel Blocker Reduces Airway Remodeling in Severe Asthma. A Proof-of-Concept Study
- Author
-
Matthieu Thumerel, Pierre-Olivier Girodet, Thomas Trian, Gaël Dournes, François Laurent, Hugues Begueret, Annaig Ozier, Isabelle Dupin, Michel Montaudon, Pierre Dos Santos, Patrick Berger, and Roger Marthan
- Subjects
Male ,Pulmonary and Respiratory Medicine ,Gallopamil ,Exacerbation ,medicine.drug_class ,Severe asthma ,Calcium channel blocker ,Critical Care and Intensive Care Medicine ,Placebo ,Double-Blind Method ,Bronchoscopy ,medicine ,Clinical endpoint ,Fiber Optic Technology ,Humans ,Asthma ,business.industry ,Bronchography ,Middle Aged ,Calcium Channel Blockers ,medicine.disease ,respiratory tract diseases ,Treatment Outcome ,Anesthesia ,Airway Remodeling ,Female ,Tomography, X-Ray Computed ,business ,Airway ,Follow-Up Studies ,medicine.drug - Abstract
Severe asthma is a major public health issue throughout the world. Increased bronchial smooth muscle (BSM) mass, a characteristic feature of airway remodeling in severe asthma, is associated with resistance to high-intensity treatment and poor prognosis. In vitro, the Ca(2+)-channel blocker gallopamil decreased the proliferation of BSM cells from patients with severe asthma.We conducted a double-blind, randomized, placebo-controlled study to evaluate the effect of gallopamil on airway remodeling in patients with severe asthma.Subjects received either gallopamil (n = 16) or placebo (n = 15) for 1 year and were monitored for an additional 3-month period. Airway remodeling was analyzed at baseline and after treatment phase using both fiberoptic bronchoscopy and computed tomography scan. The primary end point was the BSM area. Secondary end points included normalized BSM thickness and frequency of asthma exacerbations.BSM area was reduced in the gallopamil group (baseline vs. end of treatment) but was unchanged in the placebo group. Between-group differences in BSM area were not significantly different in gallopamil versus placebo groups. By contrast, between-group differences in normalized BSM thickness were significantly different between the two groups. The mean number of exacerbations per month was not different during the treatment phase in gallopamil versus placebo group but was significantly lower in patients previously treated with gallopamil during the follow-up period. There were no differences between the groups with respect to overall side effects.Gallopamil treatment for 12 months reduces BSM remodeling and prevents the occurrence of asthma exacerbations. Clinical trial registered with www.clinicaltrials.gov (NCT 00896428).
- Published
- 2015
29. Diagnostic accuracy of the International Classification of Diseases, Tenth Revision, codes of heart failure in an administrative database
- Author
-
Nicholas Moore, Pauline Bosco-Lévy, Etienne Puymirat, Véronique Gilleron, Patrick Blin, Gilles Chatellier, Pierre Dos Santos, Vincent Looten, S. Duret, François Picard, Bordeaux population health (BPH), and Université de Bordeaux (UB)-Institut de Santé Publique, d'Épidémiologie et de Développement (ISPED)-Institut National de la Santé et de la Recherche Médicale (INSERM)
- Subjects
Male ,medicine.medical_specialty ,Validation study ,Databases, Factual ,Epidemiology ,Patient Discharge Summaries ,Diagnostic accuracy ,030226 pharmacology & pharmacy ,Sensitivity and Specificity ,Cohort Studies ,Hospitals, University ,03 medical and health sciences ,0302 clinical medicine ,Administrative database ,International Classification of Diseases ,Predictive Value of Tests ,medicine ,Electronic Health Records ,Humans ,Pharmacology (medical) ,030212 general & internal medicine ,Medical diagnosis ,Diagnostic Errors ,Aged ,PharmacoEpi-Drugs ,Aged, 80 and over ,Heart Failure ,business.industry ,Incidence ,ICD-10 ,Pharmacoepidemiology ,Middle Aged ,medicine.disease ,3. Good health ,Data Accuracy ,Heart failure ,Emergency medicine ,[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie ,Female ,Diagnosis code ,France ,business ,Administrative Claims, Healthcare - Abstract
Purpose Heart failure (HF) is a common, serious, and still poorly known illness, which might benefit from studies in claims databases. However, to provide reliable estimates, HF patients must be adequately identified. This validation study aimed to estimate the diagnostic accuracy of the International Classification of Diseases, Tenth Revision (ICD-10) codes I50.x, heart failure, in the French hospital discharge diagnoses database. Methods This study was performed in two university hospitals, comparing recorded discharge diagnoses and electronic health records (EHRs). Patients with discharge ICD-10 codes 150.x were randomly selected. Their EHRs were reviewed to classify HF diagnosis as definite, potential, or miscoded based on the European Society of Cardiology diagnostic criteria, from which the codes' positive predictive value (PPV) was computed. To estimate sensitivity, patients with an EHR HF diagnosis were identified, and the presence of the I50.x codes was sought for in the hospital discharge database. Results Two hundred possible cases of HF were selected from the hospital discharge database, and 229 patients with an HF diagnosis were identified from the EHR. The PPV of I50.x codes was 60.5% (95% CI, 53.7%-67.3%) for definite HF and 88.0% (95% CI, 83.5%-92.5%) for definite/potential HF. The sensitivity of I50.x codes was 64.2% (95% CI, 58.0%-70.4%). PPV results were similar in both hospitals; sensitivity depended on the source of EHR: Departments of cardiology had a higher sensitivity than had nonspecialized wards. Conclusions Diagnosis codes I50.x in discharge summary databases accurately identify patients with HF but fail to capture some of them.
- Published
- 2017
30. Batman vs Superman - a origem da justiça: as práticas dos fãs em rede
- Author
-
Medeiros, Acácia Pierre dos Santos, Gomes, Marcelo Bolshaw, Magalhães, Henrique Paiva de, and Kneipp, Valquiria Aparecida Passos
- Subjects
Cultura participativa ,Batman vs Superman ,CIENCIAS SOCIAIS APLICADAS::COMUNICACAO: ESTUDOS DA MÍDIA [CNPQ] ,Cultura de fãs - Abstract
A expansão tecnológica e comunicacional propiciou o surgimento de novas práticas de visualização e apropriação de informações, de modo a afetar a visibilidade e as práticas das comunidades de fãs, que se constituem a partir de uma participação ativa dos membros que as integram. Este trabalho procura inserir-se no contexto da cultura participativa a fim de melhor compreender o fenômeno de cultura de fãs e contribuir para os estudos que a ele estão relacionados. Para isto, utiliza-se o filme Batman vs Superman – A Origem da Justiça com o objetivo de demonstrar como os fãs se organizam e quais as suas práticas em uma comunidade virtual. O método empregado é o da netnografia apoiada à observação das práticas online e à elaboração de questionários destinados aos membros da comunidade. A base teórica é composta por autores como Henry Jenkins (1992;2006;2009;2015), Matt Hills (2002), Clay Shirky (2011), Paul Booth (2010), Mark Duffett (2013), dentre outros que procuram compreender a participação como o fator fundamental da cultura de fãs. The technological and communicational expansion provided the emergence of new practices of preview and appropriation of information, affecting the visibility and the practices of the fans communities, which stabilish from an active participation of members that integrate them. This paper seeks to insert in the culture participatory context in order of better understand the fans culture phenomenon and contribute to the studies that are related to it. Therefore, I use Batman vs Superman – Down of Justice film to demonstrate how the fans organize themselves and which are their practices in a virtual community. The used method is the netnography with the observation of online practices and the elaboration of quizzes for the community members. The theoretical basis is composed of authors like Henry Jenkins (1992; 2006; 2009; 2015), Matt Hills (2002), Clay Shirky (2011), Paul Booth (2010), Mark Duffett (2013), and others that try to understand the participation as the key factor of the fans culture.
- Published
- 2017
31. Electrical storm in the early phase of HeartMate
- Author
-
Jerome, Corre, François, Picard, Rodrigue, Garcia, Adlane, Zemmoura, Nicolas, Derval, Arnaud, Denis, Antoine, Romen, Karine, Nubret, Pierre, Jais, Michel, Haissaguerre, Pierre, Dos Santos, Laurent, Barandon, and Frederic, Sacher
- Subjects
Male ,Time Factors ,Incidence ,Arrhythmias, Cardiac ,Stroke Volume ,Middle Aged ,Prosthesis Design ,Ventricular Function, Left ,Prosthesis Implantation ,Treatment Outcome ,Risk Factors ,Humans ,Female ,France ,Heart-Assist Devices ,Cardiomyopathies ,Aged ,Retrospective Studies - Abstract
Ventricular arrhythmia is common after left ventricular assist device (LVAD) implantation, especially in the early postoperative phase (30 days).To identify the incidence of and risk factors for electrical storm (ES) occurring within 30 days of HeartMateWe reviewed data from all consecutive patients undergoing HeartMateForty-three patients (mean age 56.7±11.2 years; 39 men) were included. At HeartMateES is a common and pejorative feature in the early postoperative period.
- Published
- 2017
32. Impact of Afterload Increase on Left Ventricular Myocardial Deformation Indices
- Author
-
Pierre Dos Santos, Alexandre Ouattara, Philippe Diolez, Alexandre Metras, Annabel Reynaud, Dominique Detaille, Béatrice Jaspard-Vinassa, Laurent Barandon, Raymond Roudaut, Patricia Reant, Stephane Lafitte, CHU Bordeaux [Bordeaux], Adaptation cardiovasculaire à l'ischémie, Université de Bordeaux (UB)-Institut National de la Santé et de la Recherche Médicale (INSERM), Department of Physiology and Pharmacology, University of Salamanca, Adaptation cardiovasculaire à l'ischemie, Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM), Biologie des maladies cardiovasculaires = Biology of Cardiovascular Diseases, Université de Bordeaux (UB)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), IHU-LIRYC, Université Bordeaux Segalen - Bordeaux 2-CHU Bordeaux [Bordeaux], Département de cardiologie, CHU Bordeaux [Bordeaux]-Hôpital Haut-Lévêque [CHU Bordeaux], Service Anesthésie - Réanimation [Bordeaux], Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Bordeaux (UB), Universidad de Salamanca, and Boullé, Christelle
- Subjects
Male ,medicine.medical_specialty ,Cardiac output ,Swine ,Blood Pressure ,030204 cardiovascular system & hematology ,Left ventricular hypertrophy ,Sensitivity and Specificity ,Muscle hypertrophy ,Contractility ,Ventricular Dysfunction, Left ,03 medical and health sciences ,Basal (phylogenetics) ,0302 clinical medicine ,Afterload ,[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,Elastic Modulus ,Internal medicine ,medicine ,Article CLINIQUE ,Animals ,Radiology, Nuclear Medicine and imaging ,030212 general & internal medicine ,ComputingMilieux_MISCELLANEOUS ,2. Zero hunger ,Ejection fraction ,business.industry ,Reproducibility of Results ,Stroke Volume ,Aortic Valve Stenosis ,medicine.disease ,Myocardial Contraction ,[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,Echocardiography ,cardiovascular system ,Cardiology ,Elasticity Imaging Techniques ,Myocardial fibrosis ,Stress, Mechanical ,Cardiology and Cardiovascular Medicine ,business - Abstract
Background Left ventricular (LV) afterload could be associated with reduced myocardial contractility. The aim of this study was to evaluate the relative impact of increased afterload on LV myocardial deformation indices in chronic aortic constriction, with regard to hypertrophy, myocardial fibrosis, and mitochondrial function, and to differentiate acute versus chronic afterload effect. Methods Young pigs underwent aortic banding ( n = 11) or sham ( n = 7) operations. Nineteen weeks later, LV morphology and systolic function, including myocardial deformation, were assessed by echocardiography before and after banding release or acute aortic constriction (in the sham group). After the animals were euthanized, mitochondrial function and LV interstitial fibrosis were assessed. Results The chronic banding group ( n = 8) presented with significant LV hypertrophy compared with the sham group ( n = 7), and longitudinal strain (LS) was significantly altered (16.9 ± 0.7% vs 20.3 ± 0.7%, P = .001) while circumferential, radial strain, and ejection fraction were not. LS abnormalities were situated mostly on the basal and mid segments and on the septal wall. There was also significantly more myocardial fibrosis in the chronic banding group compared with the sham group, while mitochondrial function was preserved. The relative contributions of hypertrophic and fibrotic remodeling and of afterload to alter global LS were 62%, and 38%, respectively. Acute aortic banding also significantly altered LS. The ratio of LS to septal wall thickness enabled differentiation between chronic and acute afterload increase (1.9 ± 0.2 in the chronic group vs 2.9 ± 0.3 in the acute group, P = .001). Conclusions LS is susceptible to both hypertrophic and fibrotic remodeling and afterload increase, particularly on the basal and mid LV segments of the septum. The ratio of LS to septal wall thickness enables differentiation of acute from chronic afterload LS alteration.
- Published
- 2016
33. Percutaneous mitral commissurotomy during pregnancy: With or without pelvic lead apron use?
- Author
-
Pierre Dos Santos, Frederic Casassus, Marina Dijos, Magdalena Murman, Pierre Coste, Lionel Leroux, and Nathalie Peragallo
- Subjects
medicine.medical_specialty ,Pregnancy ,Percutaneous ,business.industry ,valvular heart disease ,medicine.disease ,Surgery ,fashion ,fashion.garment ,medicine ,Lead apron ,Radiology ,Cardiology and Cardiovascular Medicine ,business ,Mitral commissurotomy - Published
- 2015
34. Successful transfemoral aortic Edwards®SAPIEN®bioprosthesis implantation without using iodinated contrast media in a woman with severe allergy to contrast agent
- Author
-
Marina Dijos, Lionel Leroux, and Pierre Dos Santos
- Subjects
medicine.medical_specialty ,business.industry ,media_common.quotation_subject ,valvular heart disease ,General Medicine ,Femoral artery ,medicine.disease ,Cardiac surgery ,Surgery ,Iodinated contrast media ,Stenosis ,medicine.artery ,cardiovascular system ,medicine ,Contrast (vision) ,Radiology, Nuclear Medicine and imaging ,Radiology ,Implant ,Cardiology and Cardiovascular Medicine ,business ,Edwards sapien ,media_common - Abstract
Severe anaphylactoid reaction after the use of iodinated contrast media are rare but can contraindicate the use of contrast agent. It was the case of a 53-year-old woman suffering from symptomatic severe aortic stenosis, recused for cardiac surgery because of deleterious effects of chest-wall irradiation, with porcelain aorta. We decided to implant a 23-mm Edwards® SAPIEN® transcatheter aortic valve via a femoral route without using any contrast media. The implantation was successful after surgical approach of the femoral artery, transesophageal echocardiography guiding, and localization of native leaflets and coronary trunk with catheters. Immediate and one month post-interventional follow-up was favorable and echocardiography showed a good functioning of the aortic bioprosthesis. Although conventional angiography is the best way to visualize the good positioning of the valve before deployment, our case suggests that, in special situations, transfemoral implantation of an Edwards® SAPIEN® aortic bioprosthesis is feasible without any contrast injection. © 2012 Wiley Periodicals, Inc.
- Published
- 2013
35. Endocardial Versus Epicardial Ventricular Radiofrequency Ablation
- Author
-
Laurent Roten, Nicolas Derval, Arnaud Denis, Pierre Jaïs, Pierre Bordachar, Matthew Wright, Michel Haïssaguerre, Patrizzio Pascale, Pierre Dos Santos, Khaled Ramoul, Philippe Ritter, Mélèze Hocini, and Frederic Sacher
- Subjects
medicine.medical_specialty ,Percutaneous ,Radiofrequency ablation ,Heart Ventricles ,medicine.medical_treatment ,Ventricular tachycardia ,Cardiac Catheters ,law.invention ,Contact force ,In vivo ,law ,Physiology (medical) ,Internal medicine ,medicine ,Animals ,Therapeutic Irrigation ,Endocardium ,Sheep ,business.industry ,Equipment Design ,Ablation ,medicine.disease ,Catheter ,Catheter Ablation ,Cardiology ,Cardiology and Cardiovascular Medicine ,business ,Pericardium - Abstract
Background— Contact force (CF) is an important determinant of lesion formation for atrial endocardial radiofrequency ablation. There are minimal published data on CF and ventricular lesion formation. We studied the impact of CF on lesion formation using an ovine model both endocardially and epicardially. Methods and Results— Twenty sheep received 160 epicardial and 160 endocardial ventricular radiofrequency applications using either a 3.5-mm irrigated-tip catheter (Thermocool, Biosense-Webster, n=160) or a 3.5 irrigated-tip catheter with CF assessment (Tacticath, Endosense, n=160), via percutaneous access. Power was delivered at 30 watts for 60 seconds, when either catheter/tissue contact was felt to be good or when CF>10 g with Tacticath. After completion of all lesions, acute dimensions were taken at pathology. Identifiable lesion formation from radiofrequency application was improved with the aid of CF information, from 78% to 98% on the endocardium ( P P =0.02). The mean total force was greater on the endocardium (39±18 g versus 21±14 g for the epicardium; P 3 versus 209±131 mm 3 ; P =0.02) probably because of the absence of the heat sink effect of the circulating blood and covered a greater area (41±27 mm 2 versus 29±17 mm 2 ; P =0.03) because of catheter orientation. Conclusions— In the absence of CF feedback, 22% of endocardial radiofrequency applications that are thought to have good contact did not result in lesion formation. Epicardial ablation is associated with larger lesions.
- Published
- 2013
36. Biventricular pacing in patients with Tetralogy of Fallot: Non-invasive epicardial mapping and clinical impact
- Author
-
Jean-Benoit Thambo, Pierre Dos Santos, Maxime De Guillebon, Louis Labrousse, Xavier Iriart, Michel Haïssaguerre, François Roubertie, Sylvain Ploux, Olivier Xhaet, and Pierre Bordachar
- Subjects
Adult ,Epicardial Mapping ,Male ,medicine.medical_specialty ,Time Factors ,medicine.medical_treatment ,Bundle-Branch Block ,Cardiac resynchronization therapy ,Cardiac Resynchronization Therapy ,Contractility ,Infundibulum ,Internal medicine ,Humans ,Medicine ,Prospective Studies ,cardiovascular diseases ,Prospective cohort study ,Ventricular dyssynchrony ,Tetralogy of Fallot ,business.industry ,Right bundle branch block ,medicine.disease ,medicine.anatomical_structure ,Ventricle ,cardiovascular system ,Cardiology ,Female ,Cardiology and Cardiovascular Medicine ,business ,Follow-Up Studies - Abstract
Introduction: Patients who have undergone repair of Tetralogy of Fallot (TOF) often present with right bundle branch block. Cardiac resynchronization therapy (CRT) with right ventricular (RV) or biventricular (BiV) stimulation has been proposed as a modality to correct electrical abnormalities and improve cardiac contractility in patients with repaired TOF. We aimed to 1) compare ventricular electrical activation in adults with repaired TOF during RV versus BiV stimulation, using a non-invasive epicardial mapping system, and 2) examine the clinical mid-term effects of BiV resynchronization. Methods: 9 adults with repaired TOF were implanted with a CRT system and underwent 1) a non-invasive epicardial mapping (n = 9) during sinus intrinsic rhythm, RV and BiV pacing 2) a clinical evaluation (n = 7) before and after 6 months CRT with assessment of NYHA class and exercise capacity. Results: During intrinsic rhythm, non-invasive mapping demonstrated delayed activation of the right compared with the left ventricle in all patients, with the greatest activation delay noted near the infundibulum. However, we observed important differences among patients, in the severity of activation delays. Global activation time and an index of dyssynchrony were improved (p < 0.05) during BiV pacing compared with RV pacing and spontaneous rhythm. BiV pacing increased (p < 0.05) exercise tolerance and lowered the mean NYHA functional class at 6 months of follow up. Conclusion: Patients with corrected TOF present with different patterns of ventricular activation. RV stimulation modestly improved RV activation sequence and was associated with a delayed LV activation. Biventricular stimulation significantly decreased right and left ventricular dyssynchrony. © 2011 Elsevier Ireland Ltd.
- Published
- 2013
37. Non-invasive integrative analysis of contraction energetics in intact beating heart
- Author
-
Pierre Dos Santos, Guillaume Calmettes, Mathilde Chapolard, Philippe Diolez, Michel Haïssaguerre, Richard Rouland, Veronique Deschodt-Arsac, Gilles Gouspillou, Pierre Jaïs, and Gérard Raffard
- Subjects
Beating heart ,Contraction (grammar) ,Cardiac drugs ,Energy demand ,Myocardium ,Non invasive ,Physiology ,Future application ,Human heart ,Heart ,Cell Biology ,Biology ,Adaptation, Physiological ,Myocardial Contraction ,Biochemistry ,Mitochondria, Heart ,Cardiovascular physiology ,Animals ,Humans ,Energy Metabolism ,Neuroscience - Abstract
The comprehensive study of human pathologies has revealed the complexity of the interactions involved in cardiovascular physiology. The recent validation of system's biology approaches – like our Modular Control and Regulation Analysis (MoCA) – motivates the current interest for new integrative and non-invasive analyses that could be used for medical study of human heart contraction energetics. By considering heart energetics as a supply–demand system, MoCA gives access to integrated organ function and brings out a new type of information, the “elasticities”, which describe in situ the regulation of both energy demand and supply by cellular energetic status. These regulations determine the internal control of contraction energetics and may therefore be a key to the understanding of the links between molecular events in pathologies and whole organ function/dysfunction. A wider application to the effects of cardiac drugs in conjunction with the direct study of heart pathologies may be considered in the near future. MoCA can potentially be used not only to detect the origin of the defects associated with the pathology (elasticity analyses), but also to provide a quantitative description of how these defects influence global heart function (regulation analysis) and therefore open new therapeutic perspectives. Several key examples of current applications to intact isolated beating heart are presented in this paper. The future application to human pathologies will require the use of non-invasive NMR techniques for the simultaneous measurement of energy status (31P NMR) and heart contractile activity (3D MRI). This article is part of a Directed Issue entitled: Bioenergetic dysfunction, adaptation and therapy.
- Published
- 2013
38. 0061: Arrhythmic storm in the early phase of Heart Mate® II device implantation. Incidence, risk factors and management
- Author
-
Jérôme Corré, Michel Haïssaguerre, Joachim Calderon, Pierre Jaïs, François Picard, Nicolas Derval, Pierre Dos Santos, Laurent Barandon, and Frederic Sacher
- Subjects
Body surface area ,medicine.medical_specialty ,Ejection fraction ,business.industry ,Incidence (epidemiology) ,Mortality rate ,Cardiomyopathy ,medicine.disease ,Cannula ,Transplantation ,Internal medicine ,Etiology ,medicine ,Cardiology ,business ,Cardiology and Cardiovascular Medicine - Abstract
Rhythmic complications seem common after left ventricular (LV) assist device (LVAD), especially in the early phase of implantation (
- Published
- 2016
- Full Text
- View/download PDF
39. In Vivo Phage Display to Identify New Human Antibody Fragments Homing to Atherosclerotic Endothelial and Subendothelial Tissues
- Author
-
Pierre Dos Santos, Kamel Deramchia, Stéphane Bonetto, Marie-Josée Jacobin-Valat, Hervé Bazin, Gisèle Clofent-Sanchez, Jean-Michel Franconi, Stéphane Claverol, Amélie Vallet, Xavier Santarelli, and Stéphane Sanchez
- Subjects
Male ,Phage display ,Immunoprecipitation ,Hypercholesterolemia ,Aorta, Thoracic ,Enzyme-Linked Immunosorbent Assay ,Coronary Artery Disease ,Biopanning ,Biology ,Carbonic Anhydrase II ,Epitope ,Pathology and Forensic Medicine ,Mice ,Apolipoproteins E ,Peptide Library ,In vivo ,Animals ,Humans ,Peptide library ,Mice, Knockout ,Atherosclerosis ,Dietary Fats ,Molecular biology ,Plaque, Atherosclerotic ,In vitro ,Endothelium, Vascular ,Rabbits ,Biomarkers ,Ex vivo ,Protein Binding ,Single-Chain Antibodies - Abstract
In vivo phage display selection is a powerful strategy for directly identifying agents that target the vasculature of normal or diseased tissues in living animals. We describe here a new in vivo biopanning strategy in which a human phage single-chain antibody (scFv) library was injected into high-fat diet-fed ApoE(-/-) mice. Extracellular and internalized phage scFvs were selectively recovered from atherosclerotic vascular endothelium and subjacent tissues. After three successive biopanning rounds, a panel of six clones with distinct gene sequences was isolated. Four scFvs produced and purified in soluble form were shown to interact in vitro with a rabbit atheromatous protein extract by time-resolved fluorescence resonance energy transfer and to target the endothelial cell surface and inflamed intima-related regions of rabbit and human tissue sections ex vivo. These new scFvs selected in a mouse model recognized both rabbit and human tissue, underlying the interspecies similarities of the recognized epitopes. By combining immunoprecipitation and mass spectrometry, one of the selected scFvs was shown to recognize carbonic anhydrase II, an up-regulated enzyme involved in resorption of ectopic calcification. These results show that in vivo biopanning selection in hypercholesterolemic animals makes it possible to identify both scFvs homing to atherosclerotic endothelial and subendothelial tissues, and lesion-associated biomarkers. Such scFvs offer promising opportunities in the field of molecular targeting for the treatment of atherosclerosis.
- Published
- 2012
40. Intracellular Energetic Units regulate metabolism in cardiac cells
- Author
-
Andrey V. Kuznetsov, Natalja Timohhina, Tuuli Kaambre, Kersti Tepp, Minna Karu-Varikmaa, Rita Guzun, François Boucher, Valdur Saks, Pierre Dos Santos, Marcela Gonzalez-Granillo, Laboratoire de bioénergétique fondamentale et appliquée (LBFA), Université Joseph Fourier - Grenoble 1 (UJF)-Institut National de la Santé et de la Recherche Médicale (INSERM), Laboratory of Bioenergetics, National Institute of Chemical Physics and Biophysics = Keemilise ja bioloogilise füüsika instituut [Estonie] (NICPB | KBFI), Cardiac Research Laboratory, Innsbruck Medical University [Austria] (IMU), Adaptation cardiovasculaire à l'ischémie, Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Bordeaux (UB), Physiologie cardio-Respiratoire Expérimentale Théorique et Appliquée (TIMC-IMAG-PRETA), Techniques de l'Ingénierie Médicale et de la Complexité - Informatique, Mathématiques et Applications, Grenoble - UMR 5525 (TIMC-IMAG), VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP )-Centre National de la Recherche Scientifique (CNRS)-Université Joseph Fourier - Grenoble 1 (UJF)-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP )-Centre National de la Recherche Scientifique (CNRS)-Université Joseph Fourier - Grenoble 1 (UJF), Hamant, Sarah, Innsbruck Medical University = Medizinische Universität Innsbruck (IMU), Université de Bordeaux (UB)-Institut National de la Santé et de la Recherche Médicale (INSERM), and Université Joseph Fourier - Grenoble 1 (UJF)-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP )-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)-Université Joseph Fourier - Grenoble 1 (UJF)-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP )-VetAgro Sup - Institut national d'enseignement supérieur et de recherche en alimentation, santé animale, sciences agronomiques et de l'environnement (VAS)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
Cell Membrane Permeability ,Systems biology ,Intracellular Space ,Mitochondrion ,Biology ,Creatine ,Mitochondria, Heart ,Phosphocreatine ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Tubulin ,Adenine nucleotide ,[SDV.BBM] Life Sciences [q-bio]/Biochemistry, Molecular Biology ,Animals ,Humans ,Myocyte ,Myocytes, Cardiac ,[SDV.BBM]Life Sciences [q-bio]/Biochemistry, Molecular Biology ,Cytoskeleton ,Molecular Biology ,030304 developmental biology ,0303 health sciences ,Models, Theoretical ,Cell biology ,chemistry ,Energy Metabolism ,Cardiology and Cardiovascular Medicine ,030217 neurology & neurosurgery ,Intracellular - Abstract
International audience; This review describes developments in historical perspective as well as recent results of investigations of cellular mechanisms of regulation of energy fluxes and mitochondrial respiration by cardiac work - the metabolic aspect of the Frank-Starling law of the heart. A Systems Biology solution to this problem needs the integration of physiological and biochemical mechanisms that take into account intracellular interactions of mitochondria with other cellular systems, in particular with cytoskeleton components. Recent data show that different tubulin isotypes are involved in the regular arrangement exhibited by mitochondria and ATP-consuming systems into Intracellular Energetic Units (ICEUs). Beta II tubulin association with the mitochondrial outer membrane, when co-expressed with mitochondrial creatine kinase (MtCK) specifically limits the permeability of voltage-dependent anion channel for adenine nucleotides. In the MtCK reaction this interaction changes the regulatory kinetics of respiration through a decrease in the affinity for adenine nucleotides and an increase in the affinity for creatine. Metabolic Control Analysis of the coupled MtCK-ATP Synthasome in permeabilized cardiomyocytes showed a significant increase in flux control by steps involved in ADP recycling. Mathematical modeling of compartmentalized energy transfer represented by ICEUs shows that cyclic changes in local ADP, Pi, phosphocreatine and creatine concentrations during contraction cycle represent effective metabolic feedback signals when amplified in the coupled non-equilibrium MtCK-ATP Synthasome reactions in mitochondria. This mechanism explains the regulation of respiration on beat to beat basis during workload changes under conditions of metabolic stability. This article is part of a Special Issue entitled Local Signaling in Myocytes SI.
- Published
- 2012
41. Validation of an animal model of right ventricular dysfunction and right bundle branch block to create close physiology to postoperative tetralogy of Fallot
- Author
-
Hopewell Ntsinjana, Pierre Dos Santos, Sylvain Ploux, Michel Haïssaguerre, François Roubertie, Xavier Roques, Maxime De Guillebon, Pierre Bordachar, Louis Labrousse, Stéphane Lafitte, Xavier Iriart, and J.B. Thambo
- Subjects
Adult ,medicine.medical_specialty ,Heart disease ,Swine ,Ventricular Dysfunction, Right ,Bundle-Branch Block ,Population ,Hemodynamics ,QRS complex ,Internal medicine ,medicine ,Animals ,Humans ,Ventricular outflow tract ,Prospective Studies ,education ,Ultrasonography ,Tetralogy of Fallot ,education.field_of_study ,business.industry ,Right bundle branch block ,medicine.disease ,Disease Models, Animal ,medicine.anatomical_structure ,Ventricle ,Cardiology ,Cardiology and Cardiovascular Medicine ,business - Abstract
Background In the past 5years a few number of studies and case reports have come out focusing on biventricular (BiV) stimulation for treatment of congenital heart disease related ventricular dysfunction. The few available studies include a diverse group of pathophysiological entities ranging from a previously repaired tetralogy of Fallot (TOF) to a functional single ventricle anatomy. Patient's status is too heterogeneous to build important prospective study. To well understand the implication of prolonged electromechanical dyssynchrony we performed a chronic animal model that mimics essential parameters of postoperative TOF. Methods Significant pulmonary regurgitation, mild stenosis, as well as right ventricular outflow tract (RVOT) scars were induced in 15 piglets to mimic repaired TOF. 4months after hemodynamics and dyssynchrony parameters were compared with a control group and with a population of symptomatic adult with repaired TOF. Results Comparing the animal model with the animal control group on echocardiography, RV dilatation, RV and LV dysfunction, broad QRS complex and dyssynchrony were observed on the animal model piglets. Moreover, epicardial electrical mapping showed activation consistent with a right bundle branch block. The animal models displayed the same pathophysiological parameters as the post TOF repair patients in terms of QRS duration, pulmonary regurgitation biventricular dysfunction and dyssynchrony. Conclusion This chronic swine model mimics electromechanical ventricular activation delay, RV and LV dysfunction, as in adult population of repair TOF. It does appear to be a very useful and interesting model to study the implication of dyssynchrony and the interest of resynchronization therapy in TOF failing ventricle.
- Published
- 2012
42. Cardiac Resynchronization Therapy Reduces Metaboreflex Contribution to the Ventilatory Response in Heart Failure Population
- Author
-
Pierre Dos Santos, Laurie Aimable, Hervé Douard, Laurent Barandon, Philippe Ritter, Raymond Roudaut, Jérémie Jaussaud, and Pierre Bordachar
- Subjects
lcsh:Diseases of the circulatory (Cardiovascular) system ,medicine.medical_specialty ,Article Subject ,medicine.medical_treatment ,Population ,Cardiac resynchronization therapy ,Internal medicine ,Hyperventilation ,Occlusion ,medicine ,education ,education.field_of_study ,Ejection fraction ,business.industry ,medicine.disease ,Surgery ,Blood pressure ,lcsh:RC666-701 ,Heart failure ,Circulatory system ,Clinical Study ,Cardiology ,medicine.symptom ,Cardiology and Cardiovascular Medicine ,business ,circulatory and respiratory physiology - Abstract
Background. Metaboreflex overactivation has been proprosed to explain exaggerated hyperventilation in heart failure population. We investigated the metaboreflex activation after cardiac resynchronization therapy (CRT). Methods. 10 heart failure patients (mean left ventricular ejection fraction (LVEF) 2 7 ± 4 %) schedulded for CRT implantation were prospectively studied. At baseline and after 6 month follow up two maximal cardiopulmonary exercise tests with and without regional circulatory occlusion (RCO) during recovery were performed. RCO was achieved by inflation of bilateral upper thigh tourniquets 30 mmHg above peak systolic blood pressure during 3 minutes after peak exercise. Metaboreflex contribution to the ventilatory response was assessed as the difference in ventilatory data at the third minute during recovery between the two tests (Δ). Results. Patients had enhanced VE/VCO2 slope ( 4 0 ± 9 ) and an evident metaboreflex contribution to the high ventilatory response (ΔVE: 3 ± 4 L/min; 𝑃 = 0 . 0 5 , ΔRR: 4 . 5 ± 4 /min; 𝑃 = 0 . 0 0 3 and ΔVE/VCO2: 5 . 5 ± 4 ; 𝑃 = 0 . 0 0 7 ). 6 months after CRT implantation, NYHA class, LVEF, peak VO2 and VE/VCO2 were significantly improved ( 1 . 4 ± 0 . 5 ; 𝑃 < 0 . 0 0 1 , 4 2 ± 7 %; 𝑃 < 0 . 0 0 1 , 1 6 . 5 ± 3 mL/kg/min; 𝑃 = 0 . 0 0 3 ; 3 3 ± 1 0 ; 𝑃 = 0 . 0 1 ). Metaboreflex contribution to VE, RR, and VE/VCO2 was reduced compared with baseline ( 𝑃 = 0 . 0 8 , 𝑃 = 0 . 0 1 and 𝑃 = 0 . 4 resp.). Conclusion. 6 months after CRT metaboreflex contribution to the ventilatory response is reduced.
- Published
- 2012
43. Cardiac resynchronization therapy in patients with congenital heart disease
- Author
-
Pierre Dos Santos, Thambo Jb, and Pierre Bordachar
- Subjects
Adult ,Heart Defects, Congenital ,medicine.medical_specialty ,Heart disease ,medicine.medical_treatment ,Asynchronisme ,Population ,Ventricular dyssynchrony ,Cardiac resynchronization therapy ,Heart failure ,Disease ,Sudden death ,Internal medicine ,medicine ,Humans ,cardiovascular diseases ,Intensive care medicine ,education ,Congenital heart disease ,education.field_of_study ,Evidence-Based Medicine ,Cardiopathies congénitales ,business.industry ,General Medicine ,Evidence-based medicine ,Arythmies ventriculaires ,medicine.disease ,Stimulation cardiaque de resynchronisation ,Insuffisance cardiaque ,Treatment Outcome ,Ventricular arrhythmia ,Cardiology ,Cardiology and Cardiovascular Medicine ,business - Abstract
SummaryAdults with congenital heart lesions constitute a rapidly growing group of patients with cardiovascular disease. This nascent demographic phenomenon is creating major issues concerning the optimal management of these patients, in whom sudden death and progressive heart failure are predominant causes of death. Ventricular dyssynchrony appears to be very common in this population and can appear early in the history of the disease. Recently, cardiac resynchronization therapy (CRT) has emerged as a potential treatment option for patients with congenital heart disease (CHD). In this paper, we review the clinical evidence for the role of CRT in a number of different groups of patients with congenital heart lesions. In particular, we focus on whether there is a plausible mechanistic role for CRT and, if so, whether this results in acute and longer-term beneficial effects. We conclude that CRT shows promise as a potential treatment option for patients with CHD and ventricular impairment, but larger clinical outcome studies are required before definitive guidance can be issued.
- Published
- 2011
44. GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways
- Author
-
François Vigneron, Sandrine Lemoine, Béatrice Jaspard-Vinassa, Maryline Bonnet, Thierry Couffinhal, Liliane Tariosse, Pierre Dos Santos, and Cécile Duplàa
- Subjects
medicine.medical_specialty ,Frizzled ,Potassium Channels ,Physiology ,Myocardial Infarction ,Cell Cycle Proteins ,Mice, Transgenic ,Myocardial Reperfusion Injury ,macromolecular substances ,Biology ,Glycogen Synthase Kinase 3 ,Mice ,Physiology (medical) ,Internal medicine ,medicine ,Animals ,Eukaryotic Initiation Factors ,Phosphorylation ,Protein Kinase Inhibitors ,Protein kinase B ,PI3K/AKT/mTOR pathway ,Adaptor Proteins, Signal Transducing ,Cardioprotection ,Glycogen Synthase Kinase 3 beta ,Myocardium ,TOR Serine-Threonine Kinases ,Diazoxide ,RPTOR ,Intracellular Signaling Peptides and Proteins ,Wnt signaling pathway ,Proteins ,Ribosomal Protein S6 Kinases, 70-kDa ,Free Radical Scavengers ,Phosphoproteins ,Hedgehog signaling pathway ,Cell biology ,Perfusion ,Wnt Proteins ,Disease Models, Animal ,Endocrinology ,Ischemic Preconditioning, Myocardial ,Carrier Proteins ,Reactive Oxygen Species ,Cardiology and Cardiovascular Medicine ,Proto-Oncogene Proteins c-akt ,Signal Transduction - Abstract
Aims Ischaemic preconditioning (IPC) protects the heart against prolonged lethal ischaemia through a signalling cascade involving Akt, glycogen synthase kinase-3β (GSK-3β), and mitochondrial ATP-sensitive potassium channels (mitoKATP). We previously demonstrated the involvement of the Wnt pathway in IPC in vivo via GSK-3β. A downstream target might be mammalian target of rapamycin (mTOR) since Wnt can impair tuberous sclerosis complex-2 (TSC2) phosphorylation by inhibiting GSK-3β. Here, we investigate whether the mTOR pathway is involved in cardioprotection. Methods and results Isolated-perfused mouse hearts were subjected to IPC via four cycles of ischaemia/reperfusion or pharmacological preconditioning (PPC) by diazoxide, a selective mitoKATP activator. IPC, like PPC, induced an inhibition/phosphorylation of GSK-3β through Akt activation. Preconditioning also induced phosphorylation of mTOR, p70S6K, and 4E-BP1 that correlated with a significant reduction in infarct size after 40-min ischaemia and 120-min reperfusion when compared with non-preconditioned controls. Preconditioning was impaired in GSK3 knock-in mice. In transgenic mice hearts overexpressing secreted frizzled protein 1 (sFRP1, a Wnt/Frz antagonist), GSK-3β phosphorylation, mTOR activation, and cardioprotection were impaired. Cardioprotection and its signalling were also inhibited by rapamycin (an mTOR inhibitor), 5-HD (a mitoKATP blocker), and N -(2-mercaptopropionyl) glycine (MPG) as a reactive oxygen species (ROS) scavenger. Conclusions We propose that the preconditioning signalling pathway involving an amplification loop results in a downregulation of GSK-3β and a constant opening of mitoKATP with ROS generation to activate the mTOR pathway and induce cardioprotection. The disruption of the Wnt/Frz pathway by sFRP1 modulates this loop, inducing GSK-3β activation. This study provides evidence that cardioprotection involves both a pro-survival mTOR pathway and a developmental Wnt pathway targeting GSK-3β.
- Published
- 2011
45. How should I treat a cardiac arrest during transcatheter aortic valve implantation?
- Author
-
Frederic Casassus, Sabine Bleiziffer, Louis Labrousse, Benjamin Seguy, Rüdiger Lange, Susanna Price, Marina Dijos, Pierre Dos-Santos, Lionel Leroux, and Pascal Vranckx
- Subjects
Male ,medicine.medical_specialty ,Transcatheter aortic ,business.industry ,Aortic Valve Stenosis ,Middle Aged ,Heart Arrest ,Transcatheter Aortic Valve Replacement ,Text mining ,Internal medicine ,Cardiology ,medicine ,Humans ,Intraoperative Complications ,Cardiology and Cardiovascular Medicine ,business - Published
- 2014
46. Systolic time intervals as simple echocardiographic parameters of left ventricular systolic performance: correlation with ejection fraction and longitudinal two-dimensional strain
- Author
-
Philippe Ritter, Pierre Dos Santos, Aude Mignot, Christophe Leclercq, Raymond Roudaut, Patricia Reant, Stephane Lafitte, Marina Dijos, Erwan Donal, Pierre Bordachar, and Gilbert Habib
- Subjects
Adult ,Male ,medicine.medical_specialty ,Time Factors ,Systole ,Left Ventricular Ejection Time ,Context (language use) ,Sensitivity and Specificity ,Doppler imaging ,Electrocardiography ,Ventricular Dysfunction, Left ,Internal medicine ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,Prospective Studies ,Heart Failure ,Analysis of Variance ,Ejection fraction ,medicine.diagnostic_test ,business.industry ,Reproducibility of Results ,General Medicine ,Stroke volume ,Middle Aged ,medicine.disease ,Echocardiography, Doppler ,Area Under Curve ,Case-Control Studies ,Heart failure ,Linear Models ,cardiovascular system ,Cardiology ,Female ,Cardiomyopathies ,Cardiology and Cardiovascular Medicine ,business ,circulatory and respiratory physiology - Abstract
Conventionally, the evaluation of left ventricular (LV) systolic function is based on ejection fraction assessment, which may be supplemented by other echocardiographic techniques, such as tissue Doppler imaging, 3D evaluation, and speckle tracking strains. However, these imaging modalities have a high technicity and are time-consuming, while being associated with reproducibility limitations. In this context, the usefulness of simpler measurements such as sys- tolic time intervals (STI) by pulsed Doppler echocardiography must be emphasized. Methods and results In this multicentre study, left ventricular ejection fraction (LVEF), dP/dtmax, LV stroke volume, myocardial longitudinal deformation, aortic pre-ejectional period (PEP, ms), and left ventricular ejection time (LVET, ms) were prospectively investigated and compared in 134 consecutive heart failure (HF) patients and 43 control subjects. Feasibility of STI measurements was 100%. Intra-observer reproducibility was 98% for PEP, 96% for LVET, 87% for LVEF, and 93% for global longitudinal strain (GLS). By subgroup analyses, with increasingly altered LVEF or GLS, PEP significantly increased, whereas significantly LVET decreased, resulting in a significantly increased PEP/LVET ratio (P , 0.001). In the HF patients group, a correlation between LVEF and PEP/LVET was found, with r ¼ 0.55 (y ¼ 20.0083x + 0.75, P , 0.001). Based on receiver operating curve analyses, the area under the curve was 0.91 for PEP/LVET . 0.43, which allowed us to detect LVEF , 35% with a sensitivity of 87%, and a specificity of 84%. Conclusion STI can be easily and accurately measured in clinical practice, and may be used for detecting alterations in LV systolic function. Moreover, this method is likely to have potential applications in the management of HF patients.
- Published
- 2010
47. Quantitative Analysis of Function and Perfusion during Dobutamine Stress in the Detection of Coronary Stenoses: Two-Dimensional Strain and Contrast Echocardiography Investigations
- Author
-
Raymond Roudaut, Philippe Padois, Pierre Dos Santos, P. Reant, Louis Labrousse, Stéphane Lafitte, L. Tariosse, Simone Bonoron-Adèle, and Anthony N. DeMaria
- Subjects
medicine.medical_specialty ,Swine ,Perfusion Imaging ,Contrast Media ,Sensitivity and Specificity ,Ventricular Dysfunction, Left ,Dobutamine ,Internal medicine ,medicine ,Stress Echocardiography ,Animals ,Radiology, Nuclear Medicine and imaging ,business.industry ,Coronary Stenosis ,Reproducibility of Results ,Dobutamine stress ,Echocardiography ,Contrast echocardiography ,Two dimensional strain ,Exercise Test ,Cardiology ,Elasticity Imaging Techniques ,Stress conditions ,Cardiology and Cardiovascular Medicine ,business ,Perfusion ,Radial stress ,medicine.drug - Abstract
Background The recent development of accurate methods to measure two-dimensional strain during dobutamine stress echocardiography has reactivated the debate as to the respective value of myocardial perfusion versus myocardial function assessment in detecting coronary stenoses. The aim of our study was to compare the effects of progressive coronary constrictions on two-dimensional strain and myocardial contrast echocardiography parameters during stress conditions. Methods Nine open-chest pigs were studied in the setting of various degrees of coronary constrictions. Two-dimensional strain and myocardial contrast echocardiography with Flash refilling sequence acquisitions were obtained at rest and during dobutamine infusion. Values of longitudinal strain (LS), circumferential strain (CS), radial strain (RS), and wall thickening, as well as myocardial perfusion parameter (A.b), were then calculated. Results At rest, accuracy for detecting coronary stenosis was higher for CS, LS, and A.b (74%, 67%, and 69%, respectively) than for RS or wall thickening (62% and 64%, respectively). Dobutamine stress echocardiography increased the accuracy of A.b and LS to 77% and to 73%, respectively. Sensitivity during stress was higher for CS (93%) and A.b (77%), whereas specificity was higher for LS (89%) than for other parameters. Combined evaluations (CS+A.b, CS+LS, and LS+A.b) during dobutamine stress echocardiography improved both sensitivity and accuracy for detecting coronary stenosis. Conclusion Quantitative evaluation of contraction by LS and CS analysis and perfusion (A.b) during stress echocardiography resulted in similar accuracy levels, whereas the radial component was less accurate. Maximal sensitivities and accuracies were obtained by combined evaluations during stress.
- Published
- 2010
48. Cardioprotective signaling to mitochondria
- Author
-
Pierre Dos Santos, Alexandre D.T. Costa, Casey L. Quinlan, Keith D. Garlid, and Sandrine V. Pierre
- Subjects
Cardioprotection ,Protein Kinase C-epsilon ,Biology ,Mitochondrion ,Article ,Mitochondria, Heart ,Cell biology ,Cytosol ,KATP Channels ,Mitochondrial permeability transition pore ,Caveolae ,Animals ,Humans ,Signal transduction ,Reactive Oxygen Species ,Cardiology and Cardiovascular Medicine ,Molecular Biology ,Heart metabolism ,Signal Transduction - Abstract
Mitochondria are central players in the pathophysiology of ischemia–reperfusion. Activation of plasma membrane G-coupled receptors or the Na,K-ATPase triggers cytosolic signaling pathways that result in cardioprotection. Our working hypothesis is that the occupied receptors migrate to caveolae, where signaling enzymes are scaffolded into signalosomes that bud off the plasma membrane and migrate to mitochondria. The signalosome–mitochondria interaction then initiates intramitochondrial signaling by opening the mitochondrial ATP-sensitive K + channel (mitoK ATP ). MitoK ATP opening causes an increase in ROS production, which activates mitochondrial protein kinase C epsilon (PKCɛ), which inhibits the mitochondrial permeability transition (MPT), thus decreasing cell death. We review the experimental findings that bear on these hypotheses and other modes of protection involving mitochondria.
- Published
- 2009
49. Validation of an echocardiographic multiparametric strategy to increase responders patients after cardiac resynchronization: a multicentre study
- Author
-
Frédéric Franceschi, Gilbert Habib, Hasnaa Belghiti, Jean-Claude Deharo, Antoine Deplagne, Erwan Donal, Pierre Dos Santos, Raymond Roudaut, Stéphane Lafitte, Julie Chabaneix, Pierre Bordachar, Jacques Clementy, Aude Mignot, Hannan Bougted, P. Reant, Christophe Leclercq, Amira Zaroui, Département de cardiologie, CHU Bordeaux [Bordeaux]-Hôpital Haut-Lévêque [CHU Bordeaux], CHU Bordeaux [Bordeaux], Adaptation cardiovasculaire à l'ischemie, Université Bordeaux Segalen - Bordeaux 2-Institut National de la Santé et de la Recherche Médicale (INSERM), Service de cardiologie et maladies vasculaires [Rennes] = Cardiac, Thoracic, and Vascular Surgery [Rennes], CHU Pontchaillou [Rennes], Service de cardiologie, and Université de la Méditerranée - Aix-Marseille 2-Assistance Publique - Hôpitaux de Marseille (APHM)- Hôpital de la Timone [CHU - APHM] (TIMONE)
- Subjects
Male ,medicine.medical_treatment ,Mean QRS Duration ,030204 cardiovascular system & hematology ,MESH: Epidemiologic Methods ,MESH: Stroke Volume ,Ventricular Dysfunction, Left ,MESH: Aged, 80 and over ,0302 clinical medicine ,[INFO.INFO-TS]Computer Science [cs]/Signal and Image Processing ,Mitral valve ,MESH: Ventricular Dysfunction, Left ,030212 general & internal medicine ,Ultrasonography ,Aged, 80 and over ,MESH: Aged ,MESH: Middle Aged ,Ejection fraction ,Cardiac Pacing, Artificial ,Stroke volume ,Middle Aged ,medicine.anatomical_structure ,Echocardiography ,cardiovascular system ,Cardiology ,Female ,[SDV.IB]Life Sciences [q-bio]/Bioengineering ,Cardiology and Cardiovascular Medicine ,[SPI.SIGNAL]Engineering Sciences [physics]/Signal and Image processing ,Algorithms ,medicine.medical_specialty ,Cardiac resynchronization therapy ,Heart failure ,MESH: Algorithms ,MESH: Cardiac Pacing, Artificial ,03 medical and health sciences ,[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular system ,Cardiac resynchronization ,Internal medicine ,medicine ,Humans ,cardiovascular diseases ,Systole ,Ventricular dyssynchrony ,Aged ,MESH: Humans ,business.industry ,Stroke Volume ,medicine.disease ,MESH: Male ,MESH: Heart Failure ,Epidemiologic Methods ,business ,MESH: Female - Abstract
International audience; AIMS: We sought to develop and validate a multiparametric algorithm by applying previously validated criteria to predict cardiac resynchronization therapy (CRT) response in a multicentre study. Thirty per cent of patients treated by CRT fail to respond to the treatment. Although dyssynchrony by echocardiography has been used to improve the selection of patients, the complexity of myocardial contraction has generated a moderate improvement using any of several individual parameters. METHODS AND RESULTS: Two hundred end-stage heart failure patients [NYHA 3-4 and left ventricular ejection fraction (LVEF)120 ms were included. Echocardiography analysis focused on the following parameters: atrioventricular dyssynchrony, interventricular dyssynchrony, and intraventricular dyssynchrony that integrated radial (PSAX M-mode) and longitudinal [tissue Doppler imaging (TDI)] evaluations for spatial (wall to wall) and temporal (wall end-systole to mitral valve opening) dyssynchrony diagnosis. Following CRT implantation, patients were monitored for 6 months with functional and echo evaluations defining responders by a 15% reduction in end-systolic volume. Mean QRS duration and LVEF were 152 +/- 17 ms and 25 +/- 8%. There was a CRT response in 57% of patients, independent of QRS width. Mean prevalence of positive criteria was 34 +/- 8%. Feasibility and variability averages were 81 +/- 20% and 9 +/- 4%. In a single parametric approach, ranges of sensitivities and specificities were 18-65% and 45-84% with a mean of 41% and 66%. A multiparametric approach by focusing on criteria combination decreased the mean rate of false-positive results to 14 +/- 12%, 5 +/- 4%, 2 +/- 2%, and 1 +/- 2% from one to four parameters, respectively. More than three parameters were associated with a specificity above 90% and a positive predictive value above 65%. Reproducibility of this global strategy was 91%. CONCLUSION: A multiparametric echocardiographic strategy based on the association of conventional criteria is a better indicator of CRT response than the existing single parametric approaches.
- Published
- 2009
50. Conditioning the heart induces formation of signalosomes that interact with mitochondria to open mitoKATPchannels
- Author
-
Cinthia L. Costa, Sandrine V. Pierre, Alexandre D.T. Costa, Casey L. Quinlan, Keith D. Garlid, and Pierre Dos Santos
- Subjects
Cardioprotection ,Cell signaling ,Physiology ,Bradykinin ,Beta-Cyclodextrins ,Articles ,Biology ,Mitochondrion ,Ouabain ,Cell biology ,chemistry.chemical_compound ,chemistry ,Biochemistry ,Physiology (medical) ,medicine ,Phosphorylation ,Signal transduction ,Cardiology and Cardiovascular Medicine ,medicine.drug - Abstract
Perfusion of the heart with bradykinin triggers cellular signaling events that ultimately cause opening of mitochondrial ATP-sensitive K+(mitoKATP) channels, increased H2O2production, inhibition of the mitochondrial permeability transition (MPT), and cardioprotection. We hypothesized that the interaction of bradykinin with its receptor induces the assembly of a caveolar signaling platform (signalosome) that contains the enzymes of the signaling pathway and that migrates to mitochondria to induce mitoKATPchannel opening. We developed a novel method for isolating and purifying signalosomes from Langendorff-perfused rat hearts treated with bradykinin. Fractions containing the signalosomes were found to open mitoKATPchannels in mitochondria isolated from untreated hearts via the activation of mitochondrial PKC-ε. mitoKATPchannel opening required signalosome-dependent phosphorylation of an outer membrane protein. Immunodetection analysis revealed the presence of the bradykinin B2receptor only in the fraction isolated from bradykinin-treated hearts. Immunodetection and immunogold labeling of caveolin-3, as well as sensitivity to cholesterol depletion and resistance to Triton X-100, attested to the caveolar nature of the signalosomes. Ischemic preconditioning, ischemic postconditioning, and perfusion with ouabain also led to active signalosome fractions that opened mitoKATPchannels in mitochondria from untreated hearts. These results provide initial support for a novel mechanism for signal transmission from a plasma membrane receptor to mitoKATPchannels.
- Published
- 2008
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.